| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 5.37e-06 | 5 | 164 | 3 | GO:0030156 | |
| GeneOntologyMolecularFunction | RNA polymerase binding | 1.55e-05 | 65 | 164 | 6 | GO:0070063 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 1.69e-05 | 66 | 164 | 6 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 1.69e-05 | 66 | 164 | 6 | GO:0001098 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 2.35e-05 | 21 | 164 | 4 | GO:0042975 | |
| GeneOntologyMolecularFunction | RNA polymerase core enzyme binding | 3.29e-05 | 45 | 164 | 5 | GO:0043175 | |
| GeneOntologyMolecularFunction | box C/D methylation guide snoRNP complex binding | 6.70e-05 | 2 | 164 | 2 | GO:0062064 | |
| GeneOntologyMolecularFunction | snoRNP binding | 2.00e-04 | 3 | 164 | 2 | GO:0030519 | |
| GeneOntologyMolecularFunction | RNA polymerase II complex binding | 2.88e-04 | 39 | 164 | 4 | GO:0000993 | |
| GeneOntologyMolecularFunction | DNA secondary structure binding | 3.51e-04 | 41 | 164 | 4 | GO:0000217 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent, lubricant activity | 3.98e-04 | 4 | 164 | 2 | GO:0030197 | |
| GeneOntologyMolecularFunction | TFIIB-class transcription factor binding | 9.84e-04 | 6 | 164 | 2 | GO:0001093 | |
| GeneOntologyMolecularFunction | microtubule binding | 1.03e-03 | 308 | 164 | 9 | GO:0008017 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 1.08e-03 | 55 | 164 | 4 | GO:0061733 | |
| GeneOntologyMolecularFunction | chromatin binding | NCOA3 ZNF609 BRIP1 RBL1 NR3C1 CREBBP PRDM1 ORC1 MSH6 ATXN7 ASXL3 TLE4 KMT2A ASXL2 LCOR | 1.16e-03 | 739 | 164 | 15 | GO:0003682 |
| GeneOntologyMolecularFunction | nuclear localization sequence binding | 1.38e-03 | 27 | 164 | 3 | GO:0008139 | |
| GeneOntologyMolecularFunction | transcription corepressor binding | 1.40e-03 | 59 | 164 | 4 | GO:0001222 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 1.50e-03 | 60 | 164 | 4 | GO:0034212 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 1.68e-03 | 104 | 164 | 5 | GO:0016407 | |
| GeneOntologyMolecularFunction | bubble DNA binding | 1.82e-03 | 8 | 164 | 2 | GO:0000405 | |
| GeneOntologyBiologicalProcess | epigenetic regulation of gene expression | MORC1 TET2 RBM15 TEX15 NR3C1 YTHDC1 TRIP12 PHF2 RIF1 BAZ1A KMT2A LCOR SPTY2D1 | 3.48e-06 | 330 | 169 | 13 | GO:0040029 |
| GeneOntologyBiologicalProcess | heterochromatin formation | 8.18e-06 | 163 | 169 | 9 | GO:0031507 | |
| GeneOntologyBiologicalProcess | negative regulation of gene expression, epigenetic | 4.66e-05 | 203 | 169 | 9 | GO:0045814 | |
| GeneOntologyBiologicalProcess | chromatin organization | MORC1 TET2 NCOA3 RBM15 RBL1 ZMYND8 TEX15 NR3C1 YTHDC1 TRIP12 CREBBP KANSL3 PHF2 RIF1 BAZ1A MKI67 KMT2A LCOR SPTY2D1 PRDM6 | 4.70e-05 | 896 | 169 | 20 | GO:0006325 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | MORC1 TET2 NCOA3 RBM15 CENPC RBL1 ZMYND8 TEX15 NR3C1 YTHDC1 TRIP12 CREBBP KANSL3 PHF2 RIF1 BAZ1A MKI67 KMT2A LCOR SPTY2D1 PRDM6 | 7.11e-05 | 999 | 169 | 21 | GO:0071824 |
| GeneOntologyCellularComponent | nuclear body | NOLC1 ATXN2L RBM15 AFF2 CENPC ANKS1B GON4L ZC3H18 NR3C1 YTHDC1 NR1D1 TRIP12 CREBBP SRSF12 BLM MKI67 ACIN1 SRRM2 MTDH | 1.56e-04 | 903 | 171 | 19 | GO:0016604 |
| GeneOntologyCellularComponent | dendritic spine | 1.76e-04 | 242 | 171 | 9 | GO:0043197 | |
| GeneOntologyCellularComponent | neuron spine | 2.05e-04 | 247 | 171 | 9 | GO:0044309 | |
| GeneOntologyCellularComponent | PR-DUB complex | 3.95e-04 | 4 | 171 | 2 | GO:0035517 | |
| MousePheno | increased hemolymphoid system tumor incidence | 1.95e-05 | 191 | 138 | 10 | MP:0010296 | |
| MousePheno | ectopic manchette | 3.14e-05 | 19 | 138 | 4 | MP:0009377 | |
| MousePheno | increased leukemia incidence | 3.83e-05 | 39 | 138 | 5 | MP:0002026 | |
| MousePheno | abnormal premaxilla morphology | 3.83e-05 | 39 | 138 | 5 | MP:0002820 | |
| MousePheno | abnormal hematopoietic stem cell physiology | 7.76e-05 | 45 | 138 | 5 | MP:0010763 | |
| Domain | SH3_2 | 9.81e-06 | 86 | 162 | 7 | PF07653 | |
| Domain | SH3_2 | 9.81e-06 | 86 | 162 | 7 | IPR011511 | |
| Domain | FN3_dom | COL6A3 MYLK KIAA0319L RIMBP3 PTPRO CNTN3 ROBO2 RIMBP3C RIMBP3B CDON | 1.47e-05 | 209 | 162 | 10 | IPR003961 |
| Domain | RNA_pol_II-bd | 2.19e-05 | 7 | 162 | 3 | IPR006903 | |
| Domain | CTD_bind | 2.19e-05 | 7 | 162 | 3 | PF04818 | |
| Domain | RPR | 3.47e-05 | 8 | 162 | 3 | SM00582 | |
| Domain | CID_dom | 3.47e-05 | 8 | 162 | 3 | IPR006569 | |
| Domain | CID | 3.47e-05 | 8 | 162 | 3 | PS51391 | |
| Domain | FN3 | COL6A3 MYLK KIAA0319L PTPRO CNTN3 ROBO2 RIMBP3C RIMBP3B CDON | 3.48e-05 | 185 | 162 | 9 | SM00060 |
| Domain | FN3 | 6.13e-05 | 199 | 162 | 9 | PS50853 | |
| Domain | - | 7.03e-05 | 26 | 162 | 4 | 1.25.40.90 | |
| Domain | ENTH_VHS | 1.09e-04 | 29 | 162 | 4 | IPR008942 | |
| Domain | ZF_PHD_2 | 1.78e-04 | 95 | 162 | 6 | PS50016 | |
| Domain | ZF_PHD_1 | 1.89e-04 | 96 | 162 | 6 | PS01359 | |
| Domain | SEA | 2.17e-04 | 14 | 162 | 3 | SM00200 | |
| Domain | HARE-HTH | 2.23e-04 | 3 | 162 | 2 | PF05066 | |
| Domain | ASXH | 2.23e-04 | 3 | 162 | 2 | PF13919 | |
| Domain | PHD_3 | 2.23e-04 | 3 | 162 | 2 | PF13922 | |
| Domain | ASX-like_PHD | 2.23e-04 | 3 | 162 | 2 | IPR026905 | |
| Domain | ASXH | 2.23e-04 | 3 | 162 | 2 | IPR028020 | |
| Domain | ASX/ASX-like | 2.23e-04 | 3 | 162 | 2 | IPR024811 | |
| Domain | HB1/Asxl_HTH | 2.23e-04 | 3 | 162 | 2 | IPR007759 | |
| Domain | BROMODOMAIN_2 | 4.30e-04 | 41 | 162 | 4 | PS50014 | |
| Domain | Bromodomain | 4.72e-04 | 42 | 162 | 4 | IPR001487 | |
| Domain | BROMO | 4.72e-04 | 42 | 162 | 4 | SM00297 | |
| Domain | - | 4.72e-04 | 42 | 162 | 4 | 1.20.920.10 | |
| Domain | SH3 | 6.06e-04 | 216 | 162 | 8 | SM00326 | |
| Domain | SH3 | 6.06e-04 | 216 | 162 | 8 | PS50002 | |
| Domain | SH3_domain | 6.83e-04 | 220 | 162 | 8 | IPR001452 | |
| Domain | SEA | 9.99e-04 | 23 | 162 | 3 | PS50024 | |
| Domain | SEA_dom | 9.99e-04 | 23 | 162 | 3 | IPR000082 | |
| Domain | Nuc_rcpt_coact | 1.10e-03 | 6 | 162 | 2 | IPR009110 | |
| Domain | MANSC | 1.10e-03 | 6 | 162 | 2 | PS50986 | |
| Domain | MANSC_dom | 1.10e-03 | 6 | 162 | 2 | IPR013980 | |
| Domain | Ig_I-set | 1.37e-03 | 190 | 162 | 7 | IPR013098 | |
| Domain | I-set | 1.37e-03 | 190 | 162 | 7 | PF07679 | |
| Domain | Znf_MYM | 1.53e-03 | 7 | 162 | 2 | IPR010507 | |
| Domain | zf-FCS | 1.53e-03 | 7 | 162 | 2 | PF06467 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NOLC1 ATXN2L NCOA3 RBM15 LIMA1 BRIP1 TCOF1 MAP4 ZMYND8 ARFGEF2 ZC3H18 NUP214 YTHDC1 NR1D1 TRIP12 SCAF4 BLM PCF11 KANSL3 MSH6 RIF1 USP42 ATXN7 TLE4 ZNF644 MKI67 KMT2A ACIN1 MARK2 SRRM2 PRG4 ZMYM3 MRTFA | 1.71e-21 | 774 | 171 | 33 | 15302935 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NOLC1 RBM15 ZNF609 VRK3 TCOF1 ZMYND8 ZC3H18 NUP214 YTHDC1 POM121C TRIP12 ESCO1 SCAF4 BLM KANSL3 PHF2 ORC1 RIF1 USP42 BAZ1A ZNF644 CIZ1 MKI67 KMT2A ACIN1 RPRD2 ATF1 ASXL2 DNAJC1 QSER1 CKAP2 SRRM2 LCOR MTDH SPTY2D1 HSPA9 ZMYM3 SOAT1 | 3.85e-19 | 1294 | 171 | 38 | 30804502 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NOLC1 ATXN2L RBM15 EXOSC9 ZNF609 BRIP1 CENPC MAP4 ZMYND8 ZC3H18 NUP214 TRIP12 SCAF4 SRSF12 BLM PCF11 PHF2 RIF1 BAZ1A ZNF644 CIZ1 MKI67 KMT2A ACIN1 RPRD2 ATF1 QSER1 SRRM2 LCOR MTDH | 5.60e-16 | 954 | 171 | 30 | 36373674 |
| Pubmed | NOLC1 TET2 NCOA3 LIMA1 ZNF609 ZMYND8 GON4L ZC3H18 NUP214 POM121C CREBBP SCAF4 ZIC3 PRDM1 BLM PCF11 KANSL3 PHF2 RIF1 SALL2 ZNF608 ATXN7 TLE4 ZNF644 MKI67 KMT2A RPRD2 ATF1 CEP152 ASXL2 ZMYM1 QSER1 SRRM2 ZMYM3 FILIP1L | 2.97e-15 | 1429 | 171 | 35 | 35140242 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NOLC1 TET2 ATXN2L RBM15 LIMA1 SPAST SASH1 MAP4 KIF26B STXBP4 C19orf47 TRIP12 EPN2 NEDD4 CEP350 USP31 FSIP2 MTUS1 KMT2A CEP152 CKAP2 PEAK1 MARK2 PPIP5K2 SRRM2 ARHGAP21 | 1.53e-13 | 861 | 171 | 26 | 36931259 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NOLC1 ATXN2L LIMA1 TCOF1 MAP4 STXBP4 RTN4 ZMYND8 NUP214 NR3C1 POM121C SCAF4 MSH6 RIF1 BAZ1A CIZ1 MKI67 KMT2A ACIN1 RPRD2 CKAP2 LRBA NOPCHAP1 MTDH ARHGAP21 HSPA9 | 9.67e-13 | 934 | 171 | 26 | 33916271 |
| Pubmed | Interaction network of human early embryonic transcription factors. | TET2 NCOA3 ZNF609 NUP214 POM121C CREBBP ZNF608 BAZ1A ASXL3 TLE4 ZNF644 MKI67 KMT2A ASXL2 QSER1 PRDM6 ZMYM3 | 2.20e-12 | 351 | 171 | 17 | 38297188 |
| Pubmed | NOLC1 ATXN2L NCOA3 RBM15 TCOF1 MAP4 YTHDC1 TRIP12 BLM MSH6 RIF1 C18orf21 MYPN MKI67 ACIN1 RPRD2 MARK2 SRRM2 MRTFA | 8.13e-12 | 503 | 171 | 19 | 16964243 | |
| Pubmed | NOLC1 TCOF1 ZMYND8 ZC3H18 TRIP12 ZNF644 MKI67 KMT2A ACIN1 ZMYM3 | 1.01e-10 | 103 | 171 | 10 | 32744500 | |
| Pubmed | NOLC1 TET2 ATXN2L NCOA3 RBM15 ZNF609 SPAST MAP4 ZMYND8 CREBBP SCAF4 PCF11 KANSL3 PHF2 MSH6 ZNF644 MKI67 KMT2A ATF1 ASXL2 QSER1 SRRM2 LCOR HSPA9 ZMYM3 | 2.15e-10 | 1103 | 171 | 25 | 34189442 | |
| Pubmed | GON4L NUP214 NEDD4 GRAMD1B USP31 TLE4 ZNF644 NAV3 ACIN1 ASXL2 ANKRD12 SRRM2 ARHGAP21 ZMYM3 PLCE1 PDZD2 | 2.19e-10 | 407 | 171 | 16 | 12693553 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | VRK3 RBL1 ZMYND8 NR3C1 YTHDC1 TRIP12 CREBBP BLM KANSL3 TEX36 RIF1 SALL2 BAZ1A TLE4 ZNF644 ATF1 ASXL2 QSER1 EIF2AK3 PRDM6 ZMYM3 NOVA1 | 2.90e-10 | 857 | 171 | 22 | 25609649 |
| Pubmed | EXOSC9 VRK3 MAP4 ZMYND8 CD55 GON4L YTHDC1 EPN2 SCAF4 GREB1L BLM PCF11 PHF2 ORC1 MSH6 RIF1 C18orf21 SHANK2 BAZ1A ATXN7 CIZ1 KMT2A ATF1 DNAJC1 CKAP2 MARK2 SPTY2D1 ZMYM3 | 1.22e-09 | 1497 | 171 | 28 | 31527615 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | BRIP1 VRK3 ZNF280D CENPC ZC3H18 TRIP12 BLM PHF2 FSIP2 MSH6 RIF1 BAZ1A ZNF644 CIZ1 MKI67 KMT2A QSER1 ZMYM3 | 1.47e-09 | 608 | 171 | 18 | 36089195 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | EXOSC9 MAP4 ZMYND8 ZC3H18 TRIP12 BLM PCF11 MSH6 RIF1 MKI67 ACIN1 RPRD2 MTDH | 1.78e-09 | 283 | 171 | 13 | 30585729 |
| Pubmed | TET2 NCOA3 ZNF609 ZNF280D ZMYND8 NUP214 GREB1L SALL2 ZNF608 TLE4 ZNF644 LRBA ARHGAP21 ZMYM3 MRTFA | 2.84e-09 | 418 | 171 | 15 | 34709266 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | EXOSC9 LIMA1 ZNF609 MAP4 RTN4 NR3C1 CREBBP BLM KANSL3 SALL2 ZNF608 COG1 ATXN7 ZMYM1 MTDH | 6.39e-09 | 444 | 171 | 15 | 34795231 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | NOLC1 ATXN2L RBM15 EXOSC9 MAP4 C19orf47 TRIP12 BLM MSH6 RIF1 C18orf21 BAZ1A MKI67 ACIN1 CKAP2 MARK2 EFCAB7 MTDH SPTY2D1 | 7.73e-09 | 759 | 171 | 19 | 35915203 |
| Pubmed | LIMA1 CENPC MAP4 YTHDC1 CEP350 BLM MSH6 MKI67 KMT2A CKAP2 SRRM2 | 8.49e-09 | 210 | 171 | 11 | 16565220 | |
| Pubmed | TET2 NCOA3 ZNF609 ZMYND8 CREBBP PCF11 KANSL3 ZNF608 TLE4 KMT2A RPRD2 QSER1 | 1.02e-08 | 268 | 171 | 12 | 33640491 | |
| Pubmed | NOLC1 AFF2 TCOF1 KIAA0319L ARFGEF2 MUC16 TRIP12 CEP350 BLM PCF11 RIF1 MKI67 PEAK1 LRBA MTDH SPTY2D1 ARHGAP21 HSPA9 CDON | 1.12e-08 | 777 | 171 | 19 | 35844135 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | NOLC1 ATXN2L TCOF1 ZMYND8 ZC3H18 POM121C RIF1 SENP1 ZNF644 MKI67 KMT2A ACIN1 SRRM2 | 1.65e-08 | 341 | 171 | 13 | 32971831 |
| Pubmed | TET2 EXOSC9 SPAST TCOF1 KIAA0319L ZMYND8 ANKS1B ARFGEF2 GAS7 NR1D1 TRIP12 CREBBP ZIC3 FAN1 CEP350 DIP2A OTOF COG1 NAV3 CKAP2 LRBA LCOR ARHGAP21 HSPA9 | 2.18e-08 | 1285 | 171 | 24 | 35914814 | |
| Pubmed | NOLC1 ATXN2L RBM15 TCOF1 MAP4 ZC3H18 NUP214 TRIP12 BLM MSH6 RIF1 MKI67 KMT2A ACIN1 SRRM2 HSPA9 ZMYM3 | 2.83e-08 | 653 | 171 | 17 | 22586326 | |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | RBM15 LIMA1 ZC3H18 CREBBP RIF1 MTUS1 MYPN MKI67 ACIN1 RPRD2 PEAK1 SRRM2 ARHGAP21 | 3.22e-08 | 361 | 171 | 13 | 30344098 |
| Pubmed | NOLC1 ZNF609 TCOF1 RBL1 FBF1 VPS50 ZMYND8 GAS7 ZC3H18 POM121C CREBBP PHF2 MSH6 SENP1 SALL2 ZNF608 MTUS1 ATXN7 CIZ1 SRRM2 LCOR ZMYM3 | 3.48e-08 | 1116 | 171 | 22 | 31753913 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | NOLC1 RBM15 VRK3 TCOF1 MAP4 ZMYND8 C19orf47 NUP214 YTHDC1 TRIP12 KANSL3 PHF2 MSH6 MEIOC USP42 MKI67 KMT2A ACIN1 ATF1 LRBA PPIP5K2 SRRM2 MTDH HSPA9 | 3.51e-08 | 1318 | 171 | 24 | 30463901 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NOLC1 RBM15 EXOSC9 LIMA1 GAS2L3 TCOF1 MAP4 C19orf47 NUP214 TRIP12 SCAF4 CEP350 RIF1 BAZ1A CIZ1 MKI67 ACIN1 MARK2 SRRM2 MTDH HSPA9 | 3.77e-08 | 1024 | 171 | 21 | 24711643 |
| Pubmed | COL27A1 NUP214 NR1D1 TRIP12 FAN1 PHF2 RIF1 SENP1 MKI67 SRRM2 HSPA9 | 5.10e-08 | 250 | 171 | 11 | 33536335 | |
| Pubmed | NOLC1 TET2 ZNF609 SPAST SASH1 RTN4 FBF1 VPS50 KANSL3 ZNF608 MTUS1 ROBO2 RPRD2 PPIP5K2 LCOR | 6.41e-08 | 529 | 171 | 15 | 14621295 | |
| Pubmed | NOLC1 GAS2L3 MAP4 STXBP4 CD55 TRIP12 DCX BAZ1A TLE4 MYPN ACIN1 ASXL2 ANKRD12 ZMYM1 QSER1 CKAP2 PEAK1 MTDH SPTY2D1 ARHGAP21 MRTFA | 9.79e-08 | 1084 | 171 | 21 | 11544199 | |
| Pubmed | NCOA3 ZNF609 ZNF280D ZMYND8 NR3C1 NR1D1 PRDM1 PHF2 MSH6 RIF1 BAZ1A ZNF644 CIZ1 ACIN1 ATF1 LCOR ZNF654 MRTFA | 1.13e-07 | 808 | 171 | 18 | 20412781 | |
| Pubmed | NOLC1 TET2 ATXN2L NCOA3 ZNF609 TCOF1 MAP4 ZC3H18 NUP214 POM121C MSH6 C18orf21 MKI67 ACIN1 SRRM2 HSPA9 | 1.75e-07 | 655 | 171 | 16 | 35819319 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 1.85e-07 | 123 | 171 | 8 | 26912792 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | RBM15 RTN4 VPS50 ZMYND8 NUP214 TRIP12 SCAF4 BLM DIP2A XIRP2 KMT2A MARK2 LRBA ARHGAP21 | 1.94e-07 | 497 | 171 | 14 | 36774506 |
| Pubmed | ATXN2L RBM15 EXOSC9 LIMA1 TCOF1 ZMYND8 ZC3H18 YTHDC1 TRIP12 PCF11 RIF1 BAZ1A MKI67 KMT2A ACIN1 SRRM2 MTDH ZMYM3 | 2.25e-07 | 847 | 171 | 18 | 35850772 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | ATXN2L RBM15 TCOF1 STXBP4 VPS50 C19orf47 ZC3H18 NR3C1 CREBBP RIMBP3 BLM KANSL3 SALL2 ZNF644 ZMYM3 | 2.49e-07 | 588 | 171 | 15 | 38580884 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | NOLC1 RBM15 MAP4 FBF1 ZC3H18 YTHDC1 TRIP12 PCF11 OTOF BAZ1A ASXL3 SRRM2 | 2.62e-07 | 361 | 171 | 12 | 26167880 |
| Pubmed | 2.75e-07 | 234 | 171 | 10 | 36243803 | ||
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | RBM15 GAS2L3 MAP4 C19orf47 NUP214 NR3C1 ORC1 MSH6 RIF1 BAZ1A ACIN1 MARK2 | 3.40e-07 | 370 | 171 | 12 | 22922362 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | NOLC1 RBM15 TCOF1 ZMYND8 ZC3H18 YTHDC1 TRIP12 DCX SCAF4 BLM PCF11 PHF2 MSH6 USP42 PTPRO ACIN1 PPIP5K2 SRRM2 MTDH ZMYM3 | 4.23e-07 | 1082 | 171 | 20 | 38697112 |
| Pubmed | RIM-BP3 is a manchette-associated protein essential for spermiogenesis. | 4.65e-07 | 4 | 171 | 3 | 19091768 | |
| Pubmed | 4.87e-07 | 191 | 171 | 9 | 31177093 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | ATXN2L ZNF609 CENPC TCOF1 RTN4 YTHDC1 ZIC3 BLM RIF1 SENP1 ZNF608 USP42 ZNF644 MKI67 DNAJC1 ZMYM1 SRRM2 MTDH HSPA9 ZMYM3 SOAT1 | 5.39e-07 | 1203 | 171 | 21 | 29180619 |
| Pubmed | ATXN2L LIMA1 TCOF1 MAP4 CREBBP SCAF4 MSH6 CIZ1 KMT2A ACIN1 RPRD2 QSER1 PEAK1 LRBA | 6.39e-07 | 549 | 171 | 14 | 38280479 | |
| Pubmed | NOLC1 NCOA3 RBM15 CENPC MAP4 ZMYND8 ZC3H18 YTHDC1 CREBBP BLM KANSL3 MSH6 RIF1 BAZ1A MKI67 KMT2A ACIN1 ATF1 QSER1 | 6.86e-07 | 1014 | 171 | 19 | 32416067 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | TET2 NCOA3 ZNF609 VRK3 RBL1 PCLO GON4L CREBBP ZNF608 CIZ1 ZMYM1 LCOR | 7.34e-07 | 398 | 171 | 12 | 35016035 |
| Pubmed | 9.31e-07 | 152 | 171 | 8 | 38360978 | ||
| Pubmed | 1.08e-06 | 272 | 171 | 10 | 31010829 | ||
| Pubmed | COL27A1 GAS7 YTHDC1 POM121C ESCO1 EPN2 SCAF4 FAN1 CEP350 PCF11 PHF2 CEP152 PEAK1 | 1.12e-06 | 493 | 171 | 13 | 15368895 | |
| Pubmed | ATXN2L RBM15 EXOSC9 VRK3 GAS2L3 TCOF1 MAP4 TRIP12 SCAF4 CEP350 PCF11 KANSL3 PHF2 RIF1 BAZ1A MKI67 KMT2A ACIN1 MARK2 MTDH SPTY2D1 HSPA9 | 1.15e-06 | 1371 | 171 | 22 | 36244648 | |
| Pubmed | Structure and evolution of RIM-BP genes: identification of a novel family member. | 1.16e-06 | 5 | 171 | 3 | 17855024 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | NOLC1 ZNF609 CENPC STXBP4 NUP214 ESCO1 CEP350 BLM PCF11 KANSL3 ORC1 ZNF644 MYPN CIZ1 MKI67 CEP152 ASXL2 ZMYM1 MARK2 ZMYM3 | 1.16e-06 | 1155 | 171 | 20 | 20360068 |
| Pubmed | NOLC1 CENPC TCOF1 STXBP4 RTN4 NR3C1 BLM PCF11 GRAMD1B USP31 DIP2A SENP1 ZNF644 CIZ1 DNAJC1 CKAP2 PEAK1 MARK2 SRRM2 EIF2AK3 MTDH HSPA9 SOAT1 | 1.20e-06 | 1487 | 171 | 23 | 33957083 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | ZNF609 AFF2 TCOF1 ZMYND8 NUP214 POM121C TRIP12 SH3D21 NEDD4 XIRP2 ZMYM1 MRTFA | 1.64e-06 | 430 | 171 | 12 | 35044719 |
| Pubmed | 1.70e-06 | 222 | 171 | 9 | 37071664 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | NOLC1 RBM15 TCOF1 ZMYND8 C19orf47 ZC3H18 MSH6 BAZ1A MKI67 KMT2A ACIN1 SRRM2 MTDH HSPA9 | 1.99e-06 | 605 | 171 | 14 | 28977666 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | NOLC1 RBM15 EXOSC9 CENPC TCOF1 YTHDC1 TRIP12 BLM ORC1 MSH6 RIF1 USP42 MKI67 ACIN1 SRRM2 SPTY2D1 HSPA9 SOAT1 | 2.07e-06 | 989 | 171 | 18 | 36424410 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | ATXN2L EXOSC9 TCOF1 NUP214 POM121C TRIP12 BLM PCF11 MSH6 MKI67 RPRD2 EIF2AK3 | 2.08e-06 | 440 | 171 | 12 | 34244565 |
| Pubmed | 2.42e-06 | 121 | 171 | 7 | 22412018 | ||
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | NOLC1 CENPC ZMYND8 ZC3H18 TRIP12 PHF2 MSH6 RIF1 BAZ1A MKI67 KMT2A ACIN1 SRRM2 | 2.65e-06 | 533 | 171 | 13 | 30554943 |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 3.30e-06 | 180 | 171 | 8 | 35198878 | |
| Pubmed | RECQ1 helicase is involved in replication stress survival and drug resistance in multiple myeloma. | 3.73e-06 | 183 | 171 | 8 | 28186131 | |
| Pubmed | NOLC1 NCOA3 EXOSC9 ZC3H18 NUP214 YTHDC1 TRIP12 USP42 BAZ1A KMT2A ACIN1 LCOR | 4.00e-06 | 469 | 171 | 12 | 27634302 | |
| Pubmed | RBM15 CENPC GON4L TRIP12 CREBBP CEP350 PHF2 ZNF608 CIZ1 KMT2A CEP152 CKAP2 LRBA LCOR | 4.16e-06 | 645 | 171 | 14 | 25281560 | |
| Pubmed | ZNF609 BRIP1 ZMYND8 SCAF4 BLM KANSL3 RIF1 BAZ1A RPRD2 SRRM2 ARHGAP21 MRTFA | 4.27e-06 | 472 | 171 | 12 | 38943005 | |
| Pubmed | ZNF609 RBL1 RTN4 GON4L NR3C1 FREM2 DIP2A CARD6 KMT2A QSER1 MARK2 PPIP5K2 ARHGAP21 PLCE1 | 4.55e-06 | 650 | 171 | 14 | 38777146 | |
| Pubmed | 5.89e-06 | 329 | 171 | 10 | 17474147 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 6.37e-06 | 332 | 171 | 10 | 32786267 | |
| Pubmed | NCOA3 LIMA1 ZMYND8 ARFGEF2 TRIP12 CREBBP RIF1 MKI67 ZMYM1 LCOR | 6.89e-06 | 335 | 171 | 10 | 15741177 | |
| Pubmed | 7.84e-06 | 340 | 171 | 10 | 24332808 | ||
| Pubmed | NOLC1 LIMA1 MYLK CENPC PCLO FBF1 ANKS1B TRIP12 SH3D21 PCF11 SHANK2 ZNF608 COG1 BAZ1A ATXN7 KMT2A ACIN1 PPIP5K2 MTDH ARHGAP21 HSPA9 | 9.11e-06 | 1442 | 171 | 21 | 35575683 | |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 9.17e-06 | 148 | 171 | 7 | 32538781 | |
| Pubmed | LIMA1 STXBP4 KIAA0319L UBAP1 NUP214 POM121C SALL2 COG1 TLE4 DNAJC1 PEAK1 MARK2 LRBA NOPCHAP1 MTDH SPTY2D1 HSPA9 | 1.07e-05 | 1007 | 171 | 17 | 34597346 | |
| Pubmed | 1.25e-05 | 103 | 171 | 6 | 10574462 | ||
| Pubmed | RBM15 LIMA1 SPAST TCOF1 SCAF4 ACIN1 ATF1 PPIP5K2 SRRM2 HSPA9 | 1.29e-05 | 360 | 171 | 10 | 33111431 | |
| Pubmed | 1.37e-05 | 10 | 171 | 3 | 35388142 | ||
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 1.43e-05 | 289 | 171 | 9 | 23752268 | |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | TET2 LIMA1 YTHDC1 EPN2 SCAF4 NEDD4 RIF1 CEP152 PEAK1 MARK2 PPIP5K2 LCOR | 1.52e-05 | 536 | 171 | 12 | 15840001 |
| Pubmed | 1.55e-05 | 107 | 171 | 6 | 11347906 | ||
| Pubmed | TET2 LIMA1 YTHDC1 EPN2 SCAF4 NEDD4 RIF1 CEP152 PEAK1 MARK2 PPIP5K2 LCOR | 1.58e-05 | 538 | 171 | 12 | 10512203 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | NCOA3 ZNF609 NUP214 POM121C CREBBP PCF11 RIF1 SENP1 MEIOC QSER1 HSPA9 | 1.80e-05 | 457 | 171 | 11 | 32344865 |
| Pubmed | RBM15 ZNF609 CENPC STXBP4 FAN1 CEP350 BLM PCF11 PHF2 USP31 MSH6 RIF1 MTUS1 MKI67 CKAP2 PEAK1 SRRM2 | 1.81e-05 | 1049 | 171 | 17 | 27880917 | |
| Pubmed | 1.87e-05 | 11 | 171 | 3 | 36613751 | ||
| Pubmed | Strains matter: Success of murine in vitro spermatogenesis is dependent on genetic background. | 1.87e-05 | 11 | 171 | 3 | 31421080 | |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | AFF2 MUC16 POM121C SH3D21 GRAMD1B FREM2 CLCA1 SHANK2 MTUS1 ASXL3 MUC3A NOVA1 | 2.03e-05 | 552 | 171 | 12 | 10737800 |
| Pubmed | 2.07e-05 | 33 | 171 | 4 | 19714462 | ||
| Pubmed | EXOSC9 LIMA1 MAP4 RTN4 VPS50 ZMYND8 SCAF4 MSH6 BAZ1A CKAP2 MTDH HSPA9 | 2.34e-05 | 560 | 171 | 12 | 35241646 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 10706619 | ||
| Pubmed | Some human KIR haplotypes contain two KIR2DL5 genes: KIR2DL5A and KIR2DL5B. | 2.40e-05 | 2 | 171 | 2 | 12185535 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 23076336 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 11960710 | ||
| Pubmed | Gene structure and promoter variation of expressed and nonexpressed variants of the KIR2DL5 gene. | 2.40e-05 | 2 | 171 | 2 | 11086080 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 12205094 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 20730097 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 25265234 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 30136158 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 25015830 | ||
| Pubmed | Association of KIR2DL5B gene with celiac disease supports the susceptibility locus on 19q13.4. | 2.40e-05 | 2 | 171 | 2 | 17215859 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 28232158 | ||
| Interaction | NUP43 interactions | RBM15 ZNF609 BRIP1 SPAST ZNF280D CENPC MAP4 ZMYND8 GON4L ZC3H18 NUP214 YTHDC1 POM121C TRIP12 BLM KANSL3 PHF2 FSIP2 RIF1 SENP1 SALL2 ZNF608 BAZ1A ZNF644 CIZ1 MKI67 KMT2A ACIN1 ASXL2 ZMYM1 SRRM2 LCOR ZMYM3 PDZD2 | 1.03e-18 | 625 | 165 | 34 | int:NUP43 |
| Interaction | H2BC21 interactions | VRK3 ZNF280D PCLO ZMYND8 ZC3H18 TRIP12 CREBBP ESCO1 SCAF4 BLM PHF2 ORC1 MSH6 RIF1 OTOF USP42 BAZ1A ZNF644 MKI67 KMT2A NEIL3 RPRD2 QSER1 CKAP2 SRRM2 LCOR ZMYM3 | 1.67e-11 | 696 | 165 | 27 | int:H2BC21 |
| Interaction | SNRNP40 interactions | RBM15 ZNF609 BRIP1 ZNF280D CENPC TCOF1 RBL1 GON4L ZC3H18 YTHDC1 POM121C SCAF4 BLM SENP1 ZNF608 USP42 ZNF644 CIZ1 MKI67 KMT2A ACIN1 ZMYM1 SRRM2 MTDH SPTY2D1 | 8.03e-11 | 637 | 165 | 25 | int:SNRNP40 |
| Interaction | SMC5 interactions | NOLC1 ATXN2L RBM15 EXOSC9 ZNF609 BRIP1 CENPC MAP4 ZMYND8 ZC3H18 NUP214 TRIP12 SCAF4 SRSF12 BLM PCF11 PHF2 RIF1 BAZ1A ZNF644 CIZ1 MKI67 KMT2A ACIN1 RPRD2 ATF1 QSER1 SRRM2 LCOR MTDH | 5.89e-10 | 1000 | 165 | 30 | int:SMC5 |
| Interaction | TERF2IP interactions | ZNF609 BRIP1 CENPC ZMYND8 ZC3H18 TRIP12 CREBBP BLM PCF11 KANSL3 ORC1 RIF1 SALL2 ZNF608 ZNF644 CIZ1 MKI67 KMT2A ZMYM1 QSER1 SRRM2 ZMYM3 | 9.17e-10 | 552 | 165 | 22 | int:TERF2IP |
| Interaction | HDAC2 interactions | TET2 EXOSC9 LIMA1 ZNF609 MAP4 RBL1 ZMYND8 CD55 ZC3H18 NR3C1 CREBBP ESCO1 PRDM1 KANSL3 SENP1 BAZ1A ZNF644 MKI67 KMT2A TGIF2LX RPRD2 LRBA SRRM2 PRDM6 ZMYM3 | 3.98e-08 | 865 | 165 | 25 | int:HDAC2 |
| Interaction | YWHAH interactions | NOLC1 TET2 ATXN2L NCOA3 RBM15 LIMA1 SPAST SASH1 KIF26B STXBP4 C19orf47 NR3C1 TRIP12 CREBBP EPN2 SRSF12 NEDD4 CEP350 USP31 MTUS1 KMT2A CEP152 PEAK1 MARK2 LRBA PPIP5K2 SRRM2 ARHGAP21 | 8.44e-08 | 1102 | 165 | 28 | int:YWHAH |
| Interaction | YWHAG interactions | NOLC1 TET2 ATXN2L RBM15 LIMA1 SPAST SASH1 KIF26B STXBP4 C19orf47 TRIP12 EPN2 SRSF12 NEDD4 CEP350 USP31 MTUS1 BAZ1A KMT2A ACIN1 CKAP2 PEAK1 MARK2 LRBA PPIP5K2 SRRM2 EFCAB7 ARHGAP21 HSPA9 ZMYM3 | 9.17e-08 | 1248 | 165 | 30 | int:YWHAG |
| Interaction | NAA40 interactions | NOLC1 ATXN2L LIMA1 TCOF1 MAP4 STXBP4 RTN4 ZMYND8 NUP214 NR3C1 POM121C SCAF4 MSH6 RIF1 BAZ1A CIZ1 MKI67 KMT2A ACIN1 RPRD2 CKAP2 LRBA NOPCHAP1 MTDH ARHGAP21 HSPA9 | 1.08e-07 | 978 | 165 | 26 | int:NAA40 |
| Interaction | YWHAQ interactions | NOLC1 TET2 ATXN2L NCOA3 LIMA1 TGIF2LY VRK3 SASH1 ZNF280D MAP4 KIF26B C19orf47 TRIP12 EPN2 SRSF12 NEDD4 CEP350 USP31 MTUS1 USP42 BAZ1A KMT2A PEAK1 MARK2 LRBA PPIP5K2 ARHGAP21 SOAT1 | 1.14e-07 | 1118 | 165 | 28 | int:YWHAQ |
| Interaction | XRCC6 interactions | EXOSC9 VRK3 MAP4 ZMYND8 ZC3H18 TRIP12 CREBBP BLM PCF11 PHF2 ORC1 MSH6 RIF1 BAZ1A ASXL3 MKI67 KMT2A ACIN1 NEIL3 RPRD2 ASXL2 SRRM2 MTDH HSPA9 VCAM1 | 1.53e-07 | 928 | 165 | 25 | int:XRCC6 |
| Interaction | ZNF330 interactions | NOLC1 EXOSC9 CENPC ZMYND8 ZC3H18 YTHDC1 TRIP12 BLM PHF2 MSH6 BAZ1A ZNF644 CIZ1 KMT2A LCOR SPTY2D1 ZMYM3 | 1.60e-07 | 446 | 165 | 17 | int:ZNF330 |
| Interaction | TOP1 interactions | ATXN2L RBM15 TCOF1 RBL1 ZMYND8 ZC3H18 NR3C1 YTHDC1 SCAF4 PCF11 MSH6 BAZ1A ASXL3 MKI67 KMT2A ACIN1 RPRD2 SRRM2 MTDH SPTY2D1 VCAM1 | 2.68e-07 | 696 | 165 | 21 | int:TOP1 |
| Interaction | CEBPA interactions | NOLC1 TET2 ATXN2L NCOA3 RBM15 ZNF609 SPAST MAP4 RBL1 ZMYND8 NR3C1 CREBBP SCAF4 PCF11 KANSL3 PHF2 MSH6 BAZ1A ZNF644 MKI67 KMT2A ACIN1 ATF1 ASXL2 QSER1 SRRM2 LCOR HSPA9 ZMYM3 | 3.01e-07 | 1245 | 165 | 29 | int:CEBPA |
| Interaction | DENND2D interactions | 4.37e-07 | 36 | 165 | 6 | int:DENND2D | |
| Interaction | GSC interactions | 5.75e-07 | 87 | 165 | 8 | int:GSC | |
| Interaction | H3C3 interactions | BRIP1 ZNF280D CENPC ZC3H18 TRIP12 BLM PHF2 FSIP2 MSH6 RIF1 BAZ1A ZNF644 CIZ1 MKI67 KMT2A QSER1 ZMYM3 | 6.90e-07 | 495 | 165 | 17 | int:H3C3 |
| Interaction | SSRP1 interactions | NOLC1 RBM15 ZMYND8 ZC3H18 YTHDC1 SCAF4 PCF11 PHF2 MSH6 RIF1 ZNF644 KMT2A ACIN1 ROBO2 RPRD2 SRRM2 MTDH SPTY2D1 VCAM1 MRTFA | 8.81e-07 | 685 | 165 | 20 | int:SSRP1 |
| Interaction | FEV interactions | NCOA3 ZNF609 CREBBP ZNF608 TLE4 ZNF644 KMT2A ATF1 ASXL2 QSER1 ZMYM3 | 9.40e-07 | 203 | 165 | 11 | int:FEV |
| Interaction | YWHAZ interactions | NOLC1 TET2 ATXN2L RBM15 LIMA1 SASH1 KIF26B ZC3H18 TRIP12 STAC EPN2 FAN1 NEDD4 GRAMD1B USP31 FSIP2 MTUS1 PTPRO ASXL3 ZNF644 KMT2A ASXL2 PEAK1 MARK2 PPIP5K2 ARHGAP21 HSPA9 VCAM1 SOAT1 | 9.83e-07 | 1319 | 165 | 29 | int:YWHAZ |
| Interaction | MEN1 interactions | NOLC1 ATXN2L RBM15 EXOSC9 ZNF609 TCOF1 ZMYND8 ZC3H18 YTHDC1 POM121C TRIP12 PCF11 KANSL3 RIF1 SENP1 ZNF608 BAZ1A ZNF644 MKI67 KMT2A ACIN1 QSER1 SRRM2 MTDH ZMYM3 | 1.04e-06 | 1029 | 165 | 25 | int:MEN1 |
| Interaction | POLR1E interactions | NOLC1 CENPC TCOF1 NR3C1 CREBBP BLM PHF2 SALL2 BAZ1A ZNF644 CIZ1 KMT2A RPRD2 LCOR | 1.19e-06 | 350 | 165 | 14 | int:POLR1E |
| Interaction | H2BC8 interactions | EXOSC9 ZNF280D CENPC ZMYND8 GON4L TRIP12 BLM PHF2 MSH6 RIF1 BAZ1A ZNF644 CIZ1 MKI67 KMT2A QSER1 CKAP2 ZMYM3 | 1.24e-06 | 576 | 165 | 18 | int:H2BC8 |
| Interaction | SUMO2 interactions | EXOSC9 CENPC MAP4 ZMYND8 NUP214 TRIP12 NEDD4 BLM MSH6 RIF1 SENP1 BAZ1A ATXN7 MKI67 ACIN1 SRRM2 HSPA9 ZMYM3 | 1.78e-06 | 591 | 165 | 18 | int:SUMO2 |
| Interaction | ERG interactions | NOLC1 TET2 NCOA3 EXOSC9 ZNF609 TRIP12 CREBBP NEDD4 ZNF608 ASXL2 QSER1 | 2.36e-06 | 223 | 165 | 11 | int:ERG |
| Interaction | TLE3 interactions | TET2 NCOA3 ZNF609 BRIP1 NR3C1 CREBBP SCAF4 PRDM1 ZNF608 TLE4 KMT2A ASXL2 SRRM2 LCOR | 2.75e-06 | 376 | 165 | 14 | int:TLE3 |
| Interaction | EN1 interactions | 3.44e-06 | 110 | 165 | 8 | int:EN1 | |
| Interaction | PAX8 interactions | 3.68e-06 | 111 | 165 | 8 | int:PAX8 | |
| Interaction | HNF1B interactions | TET2 NCOA3 ZNF609 TCOF1 CREBBP PRDM1 ZNF608 ATF1 ASXL2 QSER1 | 3.86e-06 | 190 | 165 | 10 | int:HNF1B |
| Interaction | HDAC1 interactions | NOLC1 TET2 ZNF609 RBL1 ZMYND8 GON4L NUP214 NR3C1 CREBBP ESCO1 PRDM1 MSH6 SENP1 ZNF608 BAZ1A TLE4 MKI67 KMT2A TGIF2LX LRBA LCOR PRDM6 ARHGAP21 ZMYM3 MRTFA | 3.89e-06 | 1108 | 165 | 25 | int:HDAC1 |
| Interaction | SFN interactions | NOLC1 TET2 ATXN2L LIMA1 SASH1 MAP4 KIF26B STXBP4 ZC3H18 NR3C1 TRIP12 CEP350 USP31 MTUS1 KMT2A PEAK1 MARK2 SRRM2 ARHGAP21 | 4.12e-06 | 692 | 165 | 19 | int:SFN |
| Interaction | EYA4 interactions | TET2 ATXN2L NCOA3 ZNF609 CREBBP ZNF608 CIZ1 QSER1 PPIP5K2 SPTY2D1 SOAT1 | 5.38e-06 | 243 | 165 | 11 | int:EYA4 |
| Interaction | ASF1A interactions | BRIP1 CENPC BLM PHF2 RIF1 SALL2 ZNF644 KMT2A QSER1 LCOR SPTY2D1 | 6.78e-06 | 249 | 165 | 11 | int:ASF1A |
| Interaction | KDM1A interactions | TET2 NCOA3 ZNF609 ZNF280D VPS50 ZMYND8 NUP214 NR3C1 ESCO1 PRDM1 GREB1L CEP350 MSH6 SALL2 ZNF608 TLE4 ZNF644 CEP152 LRBA ARHGAP21 ZMYM3 MRTFA | 9.06e-06 | 941 | 165 | 22 | int:KDM1A |
| Interaction | CAMSAP2 interactions | 1.08e-05 | 169 | 165 | 9 | int:CAMSAP2 | |
| Interaction | POLR1G interactions | NOLC1 CENPC TCOF1 ZMYND8 ZC3H18 TRIP12 BLM PHF2 ZNF644 CIZ1 KMT2A RPRD2 SRRM2 LCOR ZMYM3 | 1.25e-05 | 489 | 165 | 15 | int:POLR1G |
| Interaction | H3C1 interactions | EXOSC9 BRIP1 ZNF280D CENPC ZMYND8 NR3C1 TRIP12 CREBBP ESCO1 BLM MSH6 RIF1 XIRP2 BAZ1A ZNF644 MKI67 NAV3 KMT2A LCOR PRDM6 PDZD2 | 1.54e-05 | 901 | 165 | 21 | int:H3C1 |
| Interaction | HNF4A interactions | NCOA3 ZNF609 CREBBP BLM KANSL3 ZNF608 ATXN7 ZNF644 ASXL2 QSER1 ZMYM3 | 1.72e-05 | 275 | 165 | 11 | int:HNF4A |
| Interaction | H2BC5 interactions | NOLC1 TCOF1 MAP4 PCLO FBF1 ZC3H18 EPN2 CEP350 MSH6 MKI67 KMT2A SRRM2 | 1.89e-05 | 331 | 165 | 12 | int:H2BC5 |
| Interaction | PHLPP1 interactions | ATXN2L RBM15 LIMA1 TCOF1 MAP4 KIF26B RTN4 NUP214 NEDD4 MYPN MARK2 SOAT1 | 2.01e-05 | 333 | 165 | 12 | int:PHLPP1 |
| Interaction | YY1 interactions | ATXN2L ZMYND8 GON4L TRIP12 CREBBP NEDD4 KANSL3 RIF1 ZNF644 MKI67 KMT2A ASXL2 ZMYM1 ZMYM3 | 2.32e-05 | 454 | 165 | 14 | int:YY1 |
| Interaction | CBX3 interactions | BRIP1 ZNF280D CENPC TCOF1 ZMYND8 TRIP12 BLM RIF1 ZNF644 MKI67 KMT2A ASXL2 ZMYM1 SRRM2 LCOR HSPA9 ZMYM3 | 2.35e-05 | 646 | 165 | 17 | int:CBX3 |
| Interaction | TRIM36 interactions | 2.50e-05 | 144 | 165 | 8 | int:TRIM36 | |
| Interaction | NFIA interactions | 2.53e-05 | 188 | 165 | 9 | int:NFIA | |
| Interaction | SUMO1 interactions | NCOA3 FBF1 NR3C1 CREBBP SCAF4 BLM SENP1 ATXN7 MKI67 ZMYM3 MRTFA | 2.55e-05 | 287 | 165 | 11 | int:SUMO1 |
| Interaction | RHBDD1 interactions | MYLK MAP4 RTN4 NUP214 POM121C NEDD4 GRAMD1B LPCAT2 MKI67 DNAJC1 EIF2AK3 MTDH | 2.92e-05 | 346 | 165 | 12 | int:RHBDD1 |
| Interaction | YWHAE interactions | NOLC1 TET2 ATXN2L RBM15 LIMA1 SASH1 KIF26B ZC3H18 TRIP12 DCX STAC FAN1 NEDD4 USP31 KMT2A ASXL2 PEAK1 MARK2 LRBA SRRM2 EFCAB7 LCOR ARHGAP21 VCAM1 SOAT1 | 3.28e-05 | 1256 | 165 | 25 | int:YWHAE |
| Interaction | PHF20L1 interactions | 3.47e-05 | 75 | 165 | 6 | int:PHF20L1 | |
| Interaction | SOX2 interactions | TET2 ATXN2L NCOA3 COL6A3 RBM15 EXOSC9 LIMA1 ZNF609 VRK3 GAS2L3 RTN4 ZMYND8 NUP214 TRIP12 MSH6 SALL2 ZNF608 ZNF644 NAV3 KMT2A ATF1 QSER1 CKAP2 MARK2 EFCAB7 ARHGAP21 HSPA9 | 3.49e-05 | 1422 | 165 | 27 | int:SOX2 |
| Interaction | SP7 interactions | TET2 NCOA3 ZNF609 CREBBP SCAF4 PCF11 ZNF608 TLE4 RPRD2 QSER1 FILIP1L | 4.32e-05 | 304 | 165 | 11 | int:SP7 |
| Interaction | CRX interactions | TET2 NCOA3 ZNF609 CREBBP ZNF608 ATXN7 ZNF644 ASXL2 QSER1 ZMYM3 | 4.79e-05 | 254 | 165 | 10 | int:CRX |
| Interaction | TBXT interactions | 4.79e-05 | 116 | 165 | 7 | int:TBXT | |
| Interaction | RNF113A interactions | NOLC1 TET2 ATXN2L NCOA3 ZNF609 TCOF1 MAP4 ZC3H18 NUP214 POM121C MSH6 RIF1 C18orf21 MKI67 ACIN1 SRRM2 HSPA9 | 5.55e-05 | 692 | 165 | 17 | int:RNF113A |
| Interaction | RASA2 interactions | 5.63e-05 | 26 | 165 | 4 | int:RASA2 | |
| Interaction | CSNK2B interactions | NOLC1 SPAST VRK3 TCOF1 ZMYND8 ARFGEF2 ZC3H18 YTHDC1 CREBBP BLM PHF2 ORC1 ZNF644 KMT2A ATF1 VCAM1 | 5.72e-05 | 625 | 165 | 16 | int:CSNK2B |
| Interaction | KDM6A interactions | 5.78e-05 | 162 | 165 | 8 | int:KDM6A | |
| Interaction | FOXP3 interactions | RBM15 GAS2L3 MAP4 C19orf47 NUP214 NR3C1 ORC1 MSH6 RIF1 BAZ1A ACIN1 MARK2 NOVA1 | 5.87e-05 | 432 | 165 | 13 | int:FOXP3 |
| Interaction | SLFN11 interactions | COL27A1 NUP214 NR3C1 NR1D1 TRIP12 FAN1 PHF2 RIF1 SENP1 MKI67 SRRM2 HSPA9 | 6.52e-05 | 376 | 165 | 12 | int:SLFN11 |
| Interaction | PRDM1 interactions | 6.60e-05 | 84 | 165 | 6 | int:PRDM1 | |
| Interaction | PAX7 interactions | 7.32e-05 | 124 | 165 | 7 | int:PAX7 | |
| Interaction | EGR2 interactions | 8.45e-05 | 171 | 165 | 8 | int:EGR2 | |
| Interaction | HNRNPA1 interactions | RBM15 VRK3 CENPC ZC3H18 NR3C1 YTHDC1 SCAF4 NEDD4 PCF11 FREM2 ASXL3 MKI67 ACIN1 ASXL2 ANKRD12 MARK2 SRRM2 MTDH HSPA9 VCAM1 | 9.54e-05 | 945 | 165 | 20 | int:HNRNPA1 |
| Interaction | STAG2 interactions | 9.85e-05 | 224 | 165 | 9 | int:STAG2 | |
| Interaction | TLX1 interactions | 9.93e-05 | 175 | 165 | 8 | int:TLX1 | |
| Interaction | APEX1 interactions | NOLC1 EXOSC9 BRIP1 CENPC TCOF1 ZMYND8 YTHDC1 TRIP12 FAN1 NEDD4 GREB1L BLM PHF2 DIP2A RIF1 BAZ1A ZNF644 CIZ1 KMT2A ZMYM1 MARK2 LCOR MRTFA FILIP1L | 1.09e-04 | 1271 | 165 | 24 | int:APEX1 |
| Interaction | FOXI1 interactions | 1.10e-04 | 92 | 165 | 6 | int:FOXI1 | |
| Interaction | NLE1 interactions | 1.13e-04 | 228 | 165 | 9 | int:NLE1 | |
| Interaction | TRIM52 interactions | 1.14e-04 | 133 | 165 | 7 | int:TRIM52 | |
| Interaction | DOT1L interactions | ATXN2L RBM15 EXOSC9 LIMA1 TCOF1 ZMYND8 ZC3H18 YTHDC1 TRIP12 PCF11 ORC1 RIF1 BAZ1A MKI67 KMT2A ACIN1 SRRM2 ZMYM3 | 1.14e-04 | 807 | 165 | 18 | int:DOT1L |
| Interaction | DNAJC17 interactions | 1.19e-04 | 134 | 165 | 7 | int:DNAJC17 | |
| Interaction | PPIA interactions | ZNF609 BRIP1 ZMYND8 ZC3H18 RHOU SCAF4 BLM KANSL3 RIF1 BAZ1A MKI67 NEIL3 RPRD2 ASXL2 SRRM2 ARHGAP21 VCAM1 SOAT1 MRTFA | 1.25e-04 | 888 | 165 | 19 | int:PPIA |
| Interaction | SPAST interactions | 1.31e-04 | 136 | 165 | 7 | int:SPAST | |
| Interaction | MECP2 interactions | NOLC1 ATXN2L RBM15 TCOF1 ZMYND8 ZC3H18 YTHDC1 TRIP12 DCX SCAF4 BLM PCF11 PHF2 MSH6 C18orf21 USP42 PTPRO BAZ1A MKI67 ACIN1 PPIP5K2 SRRM2 MTDH ZMYM3 | 1.32e-04 | 1287 | 165 | 24 | int:MECP2 |
| Interaction | SIRT7 interactions | NOLC1 ATXN2L RBM15 TCOF1 MAP4 ZC3H18 NUP214 TRIP12 BLM MSH6 RIF1 MKI67 KMT2A ACIN1 SRRM2 HSPA9 ZMYM3 | 1.34e-04 | 744 | 165 | 17 | int:SIRT7 |
| Interaction | RNGTT interactions | 1.37e-04 | 137 | 165 | 7 | int:RNGTT | |
| Interaction | H3-3A interactions | BRIP1 VRK3 ZNF280D CENPC TRIP12 CREBBP NEDD4 BLM PHF2 MSH6 RIF1 BAZ1A ZNF644 MKI67 KMT2A QSER1 ZMYM3 | 1.45e-04 | 749 | 165 | 17 | int:H3-3A |
| Interaction | FBXO22 interactions | RBM15 RTN4 VPS50 ZMYND8 NUP214 TRIP12 SCAF4 BLM DIP2A XIRP2 KMT2A MARK2 LRBA ARHGAP21 | 1.48e-04 | 540 | 165 | 14 | int:FBXO22 |
| Interaction | POT1 interactions | 1.51e-04 | 237 | 165 | 9 | int:POT1 | |
| Interaction | CAVIN2 interactions | 1.66e-04 | 63 | 165 | 5 | int:CAVIN2 | |
| Interaction | PPP1R3A interactions | 1.92e-04 | 65 | 165 | 5 | int:PPP1R3A | |
| Interaction | ARL4D interactions | 2.03e-04 | 146 | 165 | 7 | int:ARL4D | |
| Interaction | SIRT6 interactions | ATXN2L EXOSC9 TCOF1 NUP214 POM121C TRIP12 CREBBP BLM PCF11 MSH6 SENP1 ZNF644 MKI67 RPRD2 EIF2AK3 | 2.09e-04 | 628 | 165 | 15 | int:SIRT6 |
| Interaction | KPNA3 interactions | 2.12e-04 | 248 | 165 | 9 | int:KPNA3 | |
| Interaction | ELOVL5 interactions | RTN4 KIAA0319L ARFGEF2 NR3C1 GRAMD1B COG1 DNAJC1 LRBA EIF2AK3 MTDH SOAT1 | 2.12e-04 | 364 | 165 | 11 | int:ELOVL5 |
| Interaction | DHX40 interactions | 2.18e-04 | 249 | 165 | 9 | int:DHX40 | |
| Interaction | RCOR1 interactions | PDGFRL VPS50 ZMYND8 NR3C1 YTHDC1 PRDM1 MSH6 SALL2 MKI67 LRBA ARHGAP21 ZMYM3 MRTFA | 2.22e-04 | 494 | 165 | 13 | int:RCOR1 |
| Interaction | AKAP10 interactions | 2.32e-04 | 37 | 165 | 4 | int:AKAP10 | |
| Interaction | PML interactions | NOLC1 TET2 EXOSC9 LIMA1 ZNF609 MAP4 RTN4 NR3C1 CREBBP BLM KANSL3 SENP1 ZNF608 COG1 ATXN7 KMT2A ZMYM1 MTDH ZMYM3 | 2.36e-04 | 933 | 165 | 19 | int:PML |
| Interaction | GCM1 interactions | 2.38e-04 | 68 | 165 | 5 | int:GCM1 | |
| Interaction | GATA2 interactions | 2.40e-04 | 199 | 165 | 8 | int:GATA2 | |
| Interaction | YWHAB interactions | TET2 ATXN2L LIMA1 SASH1 KIF26B TRIP12 STAC EPN2 SRSF12 NEDD4 CEP350 USP31 KMT2A PEAK1 MARK2 PPIP5K2 SRRM2 ARHGAP21 VCAM1 SOAT1 | 2.44e-04 | 1014 | 165 | 20 | int:YWHAB |
| Interaction | EMD interactions | SPAST VRK3 RBL1 RTN4 ZC3H18 YTHDC1 POM121C GRAMD1B DIP2A SENP1 LAMP3 ASXL2 DNAJC1 EIF2AK3 MTDH VCAM1 SOAT1 | 2.67e-04 | 789 | 165 | 17 | int:EMD |
| Interaction | SLX4 interactions | RBM15 BRIP1 NUP214 CREBBP CEP350 BLM MSH6 SALL2 ATXN7 ZNF644 MKI67 RPRD2 SPTY2D1 HSPA9 | 2.67e-04 | 572 | 165 | 14 | int:SLX4 |
| Interaction | SRPK2 interactions | NOLC1 RBM15 TCOF1 MAP4 ZC3H18 YTHDC1 TRIP12 SCAF4 SRSF12 PCF11 OTOF BAZ1A TLE4 MKI67 ACIN1 SRRM2 | 2.76e-04 | 717 | 165 | 16 | int:SRPK2 |
| Interaction | H2BC4 interactions | 2.92e-04 | 259 | 165 | 9 | int:H2BC4 | |
| Interaction | SYNE3 interactions | STXBP4 FBF1 NUP214 POM121C CEP350 GRAMD1B SENP1 ETAA1 CEP152 DNAJC1 EIF2AK3 ARHGAP21 | 3.06e-04 | 444 | 165 | 12 | int:SYNE3 |
| Interaction | CDC14A interactions | 3.06e-04 | 111 | 165 | 6 | int:CDC14A | |
| Interaction | H3C15 interactions | 3.13e-04 | 207 | 165 | 8 | int:H3C15 | |
| Interaction | NEK4 interactions | COL6A3 LIMA1 MAP4 RBL1 FBF1 NR3C1 GREB1L BLM ASXL3 LAMP3 ACIN1 SRRM2 EIF2AK3 HSPA9 | 3.19e-04 | 582 | 165 | 14 | int:NEK4 |
| Interaction | CSNK2A1 interactions | NOLC1 EXOSC9 SPAST TCOF1 RBL1 ZMYND8 ZC3H18 CREBBP GRAMD1B MSH6 BAZ1A ASXL3 KMT2A ACIN1 RPRD2 ATF1 ASXL2 SRRM2 MTDH | 3.20e-04 | 956 | 165 | 19 | int:CSNK2A1 |
| GeneFamily | CD molecules|Mucins | 4.71e-06 | 21 | 99 | 4 | 648 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.92e-05 | 161 | 99 | 7 | 593 | |
| GeneFamily | Zinc fingers MYM-type | 4.39e-04 | 6 | 99 | 2 | 86 | |
| GeneFamily | PDZ domain containing | 1.49e-03 | 152 | 99 | 5 | 1220 | |
| GeneFamily | PHD finger proteins | 1.51e-03 | 90 | 99 | 4 | 88 | |
| GeneFamily | Fibronectin type III domain containing | 1.87e-03 | 160 | 99 | 5 | 555 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 3.83e-03 | 17 | 99 | 2 | 486 | |
| GeneFamily | Zinc fingers C2H2-type|PR/SET domain family | 3.83e-03 | 17 | 99 | 2 | 1197 | |
| GeneFamily | CD molecules|Killer cell immunoglobulin like receptors | 4.29e-03 | 18 | 99 | 2 | 620 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | NCOA3 SPAST SASH1 CENPC ZMYND8 NR3C1 TRIP12 CREBBP NEDD4 CEP350 BLM PCF11 MSH6 RIF1 BAZ1A TLE4 NAV3 AKAP10 PPIP5K2 MRTFA FILIP1L PLCE1 | 3.68e-08 | 856 | 169 | 22 | M4500 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | NCOA3 CENPC ZMYND8 CREBBP CEP350 PCF11 RIF1 MTUS1 BAZ1A TLE4 MKI67 NAV3 PPIP5K2 | 8.32e-08 | 300 | 169 | 13 | M8702 |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | KIF26B COL27A1 ANKS1B GON4L YTHDC1 CREBBP TEX36 GRAMD1B SHANK2 ACIN1 ROBO2 MARK2 SRRM2 CDON PDZD2 | 9.39e-08 | 417 | 169 | 15 | M39224 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | LIMA1 CENPC PDGFRL CD55 CEP350 BLM RIF1 MTUS1 BAZ1A ZNF644 MKI67 ETAA1 DNAJC1 ZMYM1 QSER1 PPIP5K2 MTDH ZNF654 | 2.71e-07 | 656 | 169 | 18 | M18979 |
| Coexpression | LI_ESTROGENE_NON_MCF7_T47D_E2_RESPONSE_UP | 3.72e-06 | 17 | 169 | 4 | M48223 | |
| Coexpression | FISCHER_DREAM_TARGETS | NOLC1 EXOSC9 BRIP1 GAS2L3 CENPC TCOF1 RBL1 BLM PCF11 ORC1 MSH6 RIF1 SENP1 MKI67 NEIL3 CEP152 ZMYM1 CKAP2 EIF2AK3 HSPA9 | 4.74e-06 | 969 | 169 | 20 | M149 |
| Coexpression | GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_4D_CULTURE_UP | 6.39e-06 | 200 | 169 | 9 | M387 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | ATXN2L NCOA3 ZNF609 CENPC EVI2B NR3C1 YTHDC1 TRIP12 CREBBP PRDM1 CEP350 PCF11 DIP2A RIF1 USP42 BAZ1A ATXN7 ZNF644 KMT2A AKAP10 ASXL2 CKAP2 LRBA TMEM123 MTDH | 1.12e-05 | 1492 | 169 | 25 | M40023 |
| Coexpression | GEORGES_TARGETS_OF_MIR192_AND_MIR215 | NCOA3 BRIP1 GAS2L3 STXBP4 BLM ORC1 MSH6 SENP1 MKI67 NEIL3 ATF1 ZMYM1 EML1 EIF2AK3 MTDH SOAT1 CDON PLCE1 | 1.97e-05 | 892 | 169 | 18 | M18120 |
| Coexpression | DAZARD_UV_RESPONSE_CLUSTER_G6 | 4.48e-05 | 145 | 169 | 7 | M1810 | |
| Coexpression | SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6 | NOLC1 BRIP1 RBL1 ARFGEF2 MUC16 ORC1 MSH6 RIF1 MKI67 NEIL3 QSER1 CKAP2 | 4.50e-05 | 458 | 169 | 12 | M8520 |
| Coexpression | GSE7460_CTRL_VS_TGFB_TREATED_ACT_TREG_DN | 4.71e-05 | 199 | 169 | 8 | M5682 | |
| Coexpression | JAK2_DN.V1_DN | 4.88e-05 | 147 | 169 | 7 | M2872 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP | NOLC1 EXOSC9 GAS2L3 RBL1 VPS50 NEDD4 MSH6 RIF1 ZNF644 MKI67 ASXL2 CKAP2 HSPA9 SOAT1 | 7.88e-05 | 644 | 169 | 14 | M10501 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | LIMA1 AFF2 ZNF280D KIF26B STXBP4 ARFGEF2 RIF1 COG1 BAZ1A MKI67 ASXL2 ZMYM1 QSER1 PEAK1 LRBA VCAM1 FILIP1L | 4.86e-08 | 432 | 165 | 17 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | NOLC1 EXOSC9 AFF2 ZNF280D CENPC TCOF1 RBL1 STXBP4 VPS50 ANKS1B ARFGEF2 CEP350 BLM ORC1 MSH6 RIF1 C18orf21 SHANK2 USP42 BAZ1A TLE4 ZNF644 MKI67 ETAA1 ATF1 DNAJC1 QSER1 EFCAB7 MTDH ARHGAP21 VCAM1 | 2.64e-07 | 1459 | 165 | 31 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | MORC1 NCOA3 ZNF280D GAS2L3 MAP4 CREBBP ESCO1 ZIC3 GREB1L RIF1 CLCA1 ASXL3 ACIN1 ROBO2 NEIL3 ASXL2 ANKRD12 DNAJC1 PPIP5K2 LCOR SOAT1 CDON | 2.98e-07 | 804 | 165 | 22 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | TET2 LIMA1 VRK3 ZNF280D CENPC TCOF1 STXBP4 VPS50 DCX GREB1L BLM ORC1 RIF1 BAZ1A ZNF644 MKI67 ETAA1 NEIL3 ATF1 ASXL2 ANKRD12 ZMYM1 QSER1 LRBA PPIP5K2 EFCAB7 ZNF654 FILIP1L | 3.98e-07 | 1252 | 165 | 28 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | NOLC1 EXOSC9 ZNF280D CENPC TCOF1 RBL1 STXBP4 VPS50 ARFGEF2 CEP350 BLM ORC1 MSH6 RIF1 C18orf21 SHANK2 USP42 BAZ1A TLE4 ZNF644 MKI67 ETAA1 ATF1 DNAJC1 QSER1 EFCAB7 MTDH ARHGAP21 | 4.31e-07 | 1257 | 165 | 28 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | EXOSC9 ZNF280D PDGFRL STXBP4 ARFGEF2 EPN2 NEDD4 DIP2A RIF1 USP42 COG1 BAZ1A MKI67 CNTN3 ASXL2 ZMYM1 QSER1 CKAP2 EFCAB7 | 4.71e-07 | 629 | 165 | 19 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | COL6A3 AFF2 ZNF280D PDGFRL KIF26B ARFGEF2 NR3C1 DCX CREBBP SH3D21 SRSF12 MSH6 SENP1 LPCAT2 BAZ1A ASXL3 MKI67 NAV3 CNTN3 QSER1 PEAK1 LRBA PPIP5K2 FILIP1L | 5.88e-07 | 978 | 165 | 24 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | TET2 COL6A3 BRIP1 AFF2 MYLK KIF26B CD55 MUC16 RHOU GREB1L GRAMD1B CLCA1 ASXL3 MKI67 ROBO2 QSER1 CKAP2 PEAK1 VCAM1 PLCE1 PDZD2 | 6.93e-07 | 777 | 165 | 21 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#5_top-relative-expression-ranked_1000 | MAP4 CD55 TEX15 ESCO1 GREB1L RIF1 ASXL2 ANKRD12 PEAK1 LCOR SOAT1 | 1.93e-06 | 230 | 165 | 11 | gudmap_developingGonad_e18.5_ovary_1000_k5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000 | COL6A3 LIMA1 SPAST AFF2 ZNF280D KIF26B STXBP4 PCLO FBF1 ARFGEF2 CD55 SRSF12 COG1 BAZ1A ASXL3 MKI67 ROBO2 PEAK1 LRBA VCAM1 MRTFA CDON FILIP1L | 2.40e-06 | 985 | 165 | 23 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | TET2 COL6A3 BRIP1 AFF2 MYLK KIF26B CD55 MUC16 RHOU GREB1L CEP350 GRAMD1B CLCA1 ROBO2 PEAK1 ZMYM3 VCAM1 SOAT1 CDON PLCE1 | 2.53e-06 | 773 | 165 | 20 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | COL6A3 AFF2 CD55 MUC16 TEX15 GREB1L CEP350 PCF11 CLCA1 PTPRO ASXL3 ZNF644 MANSC4 PEAK1 NOPCHAP1 ZMYM3 SOAT1 CDON PDZD2 | 5.13e-06 | 740 | 165 | 19 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_500 | MAP4 KIF26B ARFGEF2 CD55 DCX CEP350 USP31 CLCA1 PTPRO CNTN3 RPRD2 ASXL2 LCOR NOVA1 | 6.55e-06 | 427 | 165 | 14 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_500 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | AFF2 KIF26B STXBP4 CD55 MUC16 TEX15 GREB1L CEP350 PCF11 ORC1 CLCA1 ASXL3 ROBO2 QSER1 NOPCHAP1 SOAT1 NOVA1 EMCN CDON PLCE1 | 7.45e-06 | 831 | 165 | 20 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | NOLC1 ZNF280D TCOF1 STXBP4 PCLO ARFGEF2 DCX SCAF4 TEX48 ZIC3 BLM ORC1 FREM2 RIF1 COG1 BAZ1A MKI67 DNAJC1 LRBA TMEM123 ARHGAP21 NOVA1 | 8.77e-06 | 989 | 165 | 22 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | MORC1 NCOA3 MAP4 TEX15 NR3C1 ESCO1 ZIC3 GREB1L RIF1 SENP1 CLCA1 MEIOC ACIN1 ASXL2 ANKRD12 DNAJC1 PPIP5K2 LCOR SOAT1 | 1.01e-05 | 776 | 165 | 19 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 1.02e-05 | 134 | 165 | 8 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | MORC1 GAS2L3 MAP4 CD55 TEX15 NR3C1 CREBBP ESCO1 GREB1L RIF1 MEIOC ACIN1 ASXL2 ANKRD12 DNAJC1 PEAK1 LCOR SOAT1 CDON | 1.04e-05 | 778 | 165 | 19 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | NOLC1 LIMA1 AFF2 ZNF280D CENPC STXBP4 VPS50 ARFGEF2 BLM MSH6 RIF1 C18orf21 BAZ1A ASXL3 ZNF644 MKI67 ETAA1 ZMYM1 QSER1 CKAP2 LRBA PPIP5K2 EFCAB7 ZNF654 FILIP1L | 1.12e-05 | 1241 | 165 | 25 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000 | COL6A3 AFF2 CD55 MUC16 TEX15 GREB1L PCF11 ORC1 CLCA1 ASXL3 ROBO2 MANSC4 PEAK1 NOPCHAP1 PPIP5K2 ZNF654 ZMYM3 SOAT1 CDON | 1.14e-05 | 783 | 165 | 19 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | NCOA3 MYLK GAS2L3 MAP4 NR3C1 CREBBP ESCO1 RIF1 ASXL3 ACIN1 ROBO2 NEIL3 ANKRD12 DNAJC1 ADGRE1 KCTD18 LCOR SOAT1 CDON | 1.29e-05 | 790 | 165 | 19 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_1000 | COL6A3 AFF2 KIF26B CD55 MUC16 TEX15 RHOU GREB1L ORC1 FREM2 CLCA1 ASXL3 ROBO2 PEAK1 NOPCHAP1 PPIP5K2 SOAT1 CDON PLCE1 | 1.46e-05 | 797 | 165 | 19 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | COL6A3 AFF2 KIF26B CD55 MUC16 TEX15 RHOU SH3D21 GREB1L FREM2 CLCA1 ASXL3 ROBO2 PEAK1 NOPCHAP1 PPIP5K2 SOAT1 CDON PDZD2 | 1.46e-05 | 797 | 165 | 19 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.60e-05 | 103 | 165 | 7 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K1 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_200 | 1.64e-05 | 143 | 165 | 8 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_200 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | MORC1 GAS2L3 MAP4 ESCO1 ZIC3 GREB1L RIF1 CLCA1 ASXL3 ACIN1 ROBO2 LCOR SOAT1 | 1.68e-05 | 403 | 165 | 13 | gudmap_developingGonad_e12.5_epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | MORC1 NCOA3 GAS2L3 MAP4 GAS7 CREBBP ESCO1 ZIC3 PRDM1 GREB1L RIF1 SENP1 CLCA1 ASXL3 ACIN1 ROBO2 DNAJC1 LCOR SOAT1 | 1.71e-05 | 806 | 165 | 19 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | TET2 AFF2 CENPC KIF26B SH3D21 SRSF12 PHF2 DIP2A BAZ1A NAV3 CNTN3 ANKRD12 LRBA ZMYM3 VCAM1 FILIP1L | 2.17e-05 | 607 | 165 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000 | NOLC1 COL6A3 MYLK PDGFRL KIF26B PCLO NR3C1 DCX SRSF12 BLM FREM2 LPCAT2 BAZ1A NAV3 CNTN3 PEAK1 LRBA TMEM123 EFCAB7 CDON FILIP1L | 2.24e-05 | 973 | 165 | 21 | Facebase_RNAseq_e9.5_Olfactory Placode_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | COL6A3 LIMA1 STXBP4 ARFGEF2 TEX48 ASXL3 ZNF644 MKI67 PEAK1 VCAM1 FILIP1L | 2.25e-05 | 298 | 165 | 11 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | COL6A3 AFF2 KIF26B RBL1 STXBP4 CD55 MUC16 TEX15 GREB1L CEP350 BLM ORC1 CLCA1 ASXL3 ROBO2 NOPCHAP1 ZMYM3 SOAT1 PLCE1 | 2.43e-05 | 827 | 165 | 19 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | COL6A3 KIF26B STXBP4 PCLO NR3C1 DCX TEX48 ZIC3 SRSF12 CEP350 PHF2 RIF1 MTUS1 BAZ1A TLE4 DNAJC1 PEAK1 LRBA TMEM123 NOVA1 FILIP1L | 2.60e-05 | 983 | 165 | 21 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_top-relative-expression-ranked_1000 | NOLC1 MYLK KIF26B RBL1 ARFGEF2 BLM USP31 SALL2 CLCA1 LPCAT2 PTPRO BAZ1A ASXL3 CNTN3 ADGRE1 SPTY2D1 VCAM1 EMCN PLCE1 | 2.82e-05 | 836 | 165 | 19 | gudmap_developingKidney_e15.5_Podocyte cells_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | LIMA1 AFF2 ZNF280D TCOF1 KIF26B STXBP4 PCLO ARFGEF2 BLM RIF1 COG1 BAZ1A MKI67 ASXL2 ZMYM1 QSER1 PEAK1 LRBA EFCAB7 VCAM1 FILIP1L | 2.84e-05 | 989 | 165 | 21 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_1000 | NOLC1 LIMA1 BRIP1 MYLK KIF26B RBL1 CD55 GON4L RHOU USP31 CLCA1 ASXL3 ETAA1 EML1 CKAP2 SPTY2D1 PRDM6 ZMYM3 VCAM1 | 2.87e-05 | 837 | 165 | 19 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | LIMA1 PDGFRL KIF26B ARFGEF2 NUP214 PRDM1 CEP350 USP31 FREM2 RIF1 PTPRO ASXL3 TLE4 NAV3 CNTN3 ROBO2 ASXL2 VCAM1 | 3.17e-05 | 769 | 165 | 18 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500 | LIMA1 ZNF280D KIF26B PCLO ARFGEF2 SRSF12 COG1 BAZ1A ASXL3 MKI67 PEAK1 VCAM1 CDON FILIP1L | 3.17e-05 | 492 | 165 | 14 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#3_top-relative-expression-ranked_500 | 3.50e-05 | 79 | 165 | 6 | gudmap_developingGonad_P2_ovary_500_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_top-relative-expression-ranked_200 | 3.68e-05 | 160 | 165 | 8 | gudmap_developingKidney_e15.5_Cap mesenchyme_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.88e-05 | 209 | 165 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k1 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_1000 | AFF2 KIF26B CD55 MUC16 TEX15 RHOU GREB1L PCF11 ORC1 CLCA1 ASXL3 ROBO2 NOPCHAP1 PPIP5K2 SPTY2D1 ZNF654 SOAT1 FILIP1L PLCE1 | 4.01e-05 | 858 | 165 | 19 | gudmap_dev gonad_e11.5_F_GonMes_Sma_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | COL6A3 BRIP1 AFF2 KIF26B CD55 MUC16 GAS7 RHOU GREB1L GRAMD1B CLCA1 ROBO2 CKAP2 ZMYM3 VCAM1 SOAT1 PLCE1 PDZD2 | 4.72e-05 | 793 | 165 | 18 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_200 | 4.78e-05 | 166 | 165 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_200 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | NCOA3 ZNF280D GAS2L3 MAP4 NR3C1 CREBBP ESCO1 RIF1 ASXL3 ACIN1 ROBO2 NEIL3 ANKRD12 DNAJC1 ADGRE1 LCOR SOAT1 CDON | 5.37e-05 | 801 | 165 | 18 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_500 | KIF26B ARFGEF2 NUP214 PRDM1 USP31 RIF1 PTPRO ASXL3 CNTN3 ROBO2 ASXL2 VCAM1 | 5.64e-05 | 390 | 165 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#5 | ZNF280D KIF26B ARFGEF2 CREBBP SRSF12 ASXL3 MKI67 CNTN3 QSER1 PEAK1 FILIP1L | 5.83e-05 | 331 | 165 | 11 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K5 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_1000 | 6.16e-05 | 127 | 165 | 7 | gudmap_developingGonad_e16.5_epididymis_1000_k4 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | NOLC1 LIMA1 AFF2 ZNF280D CENPC STXBP4 VPS50 ARFGEF2 BLM MSH6 RIF1 C18orf21 BAZ1A ASXL3 ZNF644 MKI67 ETAA1 ZMYM1 QSER1 CKAP2 LRBA PPIP5K2 EFCAB7 ZNF654 VCAM1 FILIP1L | 6.65e-05 | 1468 | 165 | 26 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | TET2 COL6A3 MYLK KIF26B CD55 MUC16 RHOU CEP350 CLCA1 ROBO2 VCAM1 | 6.67e-05 | 336 | 165 | 11 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | MORC1 NCOA3 ZNF280D GAS2L3 STXBP4 DCX CREBBP ESCO1 ZIC3 RIF1 SENP1 ASXL3 ACIN1 ROBO2 NEIL3 DNAJC1 LCOR SOAT1 | 6.70e-05 | 815 | 165 | 18 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_500 | 6.86e-05 | 89 | 165 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | COL6A3 LIMA1 KIF26B STXBP4 ARFGEF2 SH3D21 SRSF12 ASXL3 ZNF644 MKI67 NAV3 CNTN3 ANKRD12 PEAK1 ZMYM3 VCAM1 FILIP1L | 7.14e-05 | 744 | 165 | 17 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000 | NOLC1 COL6A3 PDGFRL KIF26B NR3C1 DCX SH3D21 ZIC3 SRSF12 GREB1L ORC1 FREM2 SALL2 LPCAT2 NAV3 CNTN3 PEAK1 EFCAB7 NOVA1 FILIP1L | 7.30e-05 | 976 | 165 | 20 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_500 | AFF2 TEX15 SH3D21 GREB1L PCF11 ORC1 NOPCHAP1 ARHGAP21 ZMYM3 SOAT1 CDON PLCE1 | 7.89e-05 | 404 | 165 | 12 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#5_top-relative-expression-ranked_1000 | 8.12e-05 | 179 | 165 | 8 | gudmap_developingGonad_e14.5_ ovary_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#3 | 8.14e-05 | 285 | 165 | 10 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | NCOA3 GAS2L3 MAP4 CREBBP ASXL3 ACIN1 ROBO2 NEIL3 DNAJC1 LCOR SOAT1 CDON | 8.27e-05 | 406 | 165 | 12 | gudmap_developingGonad_e16.5_epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500 | MORC1 GAS2L3 ESCO1 ZIC3 GREB1L RIF1 ASXL3 ACIN1 ROBO2 DNAJC1 LCOR SOAT1 | 8.86e-05 | 409 | 165 | 12 | gudmap_developingGonad_e12.5_ovary_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3 | AFF2 ZNF280D KIF26B ARFGEF2 CREBBP SRSF12 MSH6 ASXL3 MKI67 CARD6 CNTN3 ANKRD12 QSER1 PEAK1 LRBA ZMYM3 VCAM1 FILIP1L | 8.97e-05 | 834 | 165 | 18 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | AFF2 ZNF280D STXBP4 ARFGEF2 COG1 BAZ1A MKI67 PEAK1 LRBA FILIP1L | 9.66e-05 | 291 | 165 | 10 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | NCOA3 GAS2L3 MAP4 CREBBP RIF1 ASXL3 ACIN1 ROBO2 DNAJC1 LCOR SOAT1 CDON | 9.72e-05 | 413 | 165 | 12 | gudmap_developingGonad_e14.5_ epididymis_500 |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_500 | AFF2 TEX15 SH3D21 GREB1L PCF11 ORC1 CLCA1 PEAK1 NOPCHAP1 ARHGAP21 ZMYM3 SOAT1 | 9.94e-05 | 414 | 165 | 12 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.02e-04 | 293 | 165 | 10 | gudmap_developingKidney_e15.5_Podocyte cells_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | MORC1 GAS2L3 CD55 TEX15 NR3C1 CREBBP ESCO1 EPN2 GREB1L RIF1 MTUS1 ACIN1 NEIL3 ANKRD12 DNAJC1 LCOR SOAT1 | 1.08e-04 | 770 | 165 | 17 | gudmap_developingGonad_P2_ovary_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_1000 | AFF2 KIF26B CD55 MUC16 GAS7 TEX15 RHOU GREB1L ORC1 CLCA1 ASXL3 ROBO2 NOPCHAP1 SPTY2D1 ZMYM3 SOAT1 FILIP1L PLCE1 | 1.12e-04 | 849 | 165 | 18 | gudmap_dev gonad_e11.5_M_GonMes_Sma_1000 |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_k-means-cluster#3_top-relative-expression-ranked_500 | 1.17e-04 | 98 | 165 | 6 | gudmap_developingKidney_e13.5_podocyte cells_500_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_top-relative-expression-ranked_1000 | NOLC1 KIF26B RBL1 STXBP4 ARFGEF2 NUP214 DCX PIERCE2 USP31 RIF1 SALL2 CNTN3 ROBO2 AKAP10 RPRD2 CEP152 ASXL2 | 1.24e-04 | 779 | 165 | 17 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | COL6A3 AFF2 KIF26B CD55 MUC16 RHOU GREB1L GRAMD1B CLCA1 ROBO2 VCAM1 | 1.26e-04 | 361 | 165 | 11 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | NCOA3 ZNF280D MAP4 RBL1 STXBP4 ARFGEF2 UBAP1 GON4L TEX48 C18orf21 COG1 BAZ1A ZNF644 MKI67 ROBO2 NEIL3 EIF2AK3 | 1.26e-04 | 780 | 165 | 17 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.36e-04 | 246 | 165 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | ATXN2L ZNF280D VPS50 ARFGEF2 YTHDC1 EPN2 NEDD4 USP42 COG1 MKI67 ASXL2 QSER1 CKAP2 MTDH | 1.36e-04 | 564 | 165 | 14 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500_k-means-cluster#5 | 1.51e-04 | 65 | 165 | 5 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500_K5 | |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000 | MORC1 NOLC1 BRIP1 VPS50 TEX15 ZIC3 PRDM1 BLM ORC1 MSH6 RIF1 TLE4 ETAA1 ZMYM1 CKAP2 KCTD18 NOVA1 | 1.59e-04 | 795 | 165 | 17 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | TET2 AFF2 MAP4 KIF26B COL27A1 ANKS1B CD55 GAS7 GREB1L GRAMD1B USP42 ASXL3 TLE4 NAV3 ROBO2 NEIL3 ANKRD12 EML1 PEAK1 MARK2 FILIP1L PLCE1 | 1.73e-04 | 1208 | 165 | 22 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#3 | 1.77e-04 | 255 | 165 | 9 | Facebase_RNAseq_e10.5_Maxillary Arch_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#2 | TET2 COL6A3 KIF26B SH3D21 SRSF12 BLM NAV3 CARD6 CNTN3 ANKRD12 PEAK1 LRBA ZMYM3 VCAM1 FILIP1L | 1.89e-04 | 655 | 165 | 15 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K2 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_500 | TEX15 NR3C1 ESCO1 ZIC3 GREB1L RIF1 MEIOC ANKRD12 DNAJC1 LCOR SOAT1 | 2.06e-04 | 382 | 165 | 11 | gudmap_developingGonad_e14.5_ ovary_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | MAP4 KIF26B ARFGEF2 CD55 DCX CREBBP CEP350 USP31 RIF1 CLCA1 PTPRO ASXL3 CNTN3 RPRD2 ASXL2 LCOR NOVA1 | 2.22e-04 | 818 | 165 | 17 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_top-relative-expression-ranked_500 | MORC1 BRIP1 TEX15 ZIC3 PRDM1 BLM ORC1 RIF1 ETAA1 ZMYM1 CKAP2 | 2.25e-04 | 386 | 165 | 11 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.25e-04 | 323 | 165 | 10 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000_k5 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | BRIP1 VPS50 ARFGEF2 TEX15 ESCO1 ZIC3 PRDM1 BLM USP31 ORC1 RIF1 MEIOC BAZ1A ANKRD12 CKAP2 LRBA NOVA1 | 2.28e-04 | 820 | 165 | 17 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_500 | MORC1 BRIP1 TEX15 ZIC3 PRDM1 BLM ORC1 RIF1 ETAA1 CKAP2 KCTD18 | 2.30e-04 | 387 | 165 | 11 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#1 | 2.31e-04 | 157 | 165 | 7 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500_K1 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | MORC1 BRIP1 VPS50 ARFGEF2 TEX15 ZIC3 PRDM1 BLM USP31 ORC1 MSH6 RIF1 MEIOC ETAA1 ZMYM1 CKAP2 KCTD18 | 2.35e-04 | 822 | 165 | 17 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_500 | COL6A3 AFF2 CD55 MUC16 TEX15 GREB1L CLCA1 ASXL3 PEAK1 SOAT1 CDON | 2.35e-04 | 388 | 165 | 11 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | EXOSC9 ZNF280D RBL1 PCLO EPN2 USP42 COG1 MKI67 RPRD2 ASXL2 CKAP2 EFCAB7 ZNF654 NOVA1 | 2.36e-04 | 595 | 165 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_1000 | BRIP1 MYLK KIF26B RBL1 PCLO DCX BLM FREM2 SENP1 ZNF608 MTUS1 BAZ1A CNTN3 ROBO2 NEIL3 PDZD2 | 2.52e-04 | 749 | 165 | 16 | gudmap_kidney_P3_CapMes_Crym_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | STXBP4 PCLO UBAP1 GON4L TEX48 RIF1 COG1 BAZ1A MKI67 ROBO2 NEIL3 DNAJC1 KCTD18 EIF2AK3 ARHGAP21 MRTFA NOVA1 | 2.66e-04 | 831 | 165 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | COL6A3 KIF26B RBL1 STXBP4 CD55 MUC16 GREB1L CLCA1 ASXL3 ROBO2 | 3.16e-04 | 337 | 165 | 10 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | TET2 COL6A3 AFF2 KIF26B CD55 MUC16 GAS7 GREB1L GRAMD1B CLCA1 ASXL3 ROBO2 ZMYM3 VCAM1 SOAT1 PLCE1 | 3.32e-04 | 768 | 165 | 16 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_500 | MORC1 BRIP1 TEX15 ZIC3 PRDM1 BLM ORC1 RIF1 MEIOC ZMYM1 CKAP2 | 3.46e-04 | 406 | 165 | 11 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_500 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.49e-04 | 168 | 165 | 7 | gudmap_developingGonad_P2_ovary_1000_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#2 | 3.70e-04 | 121 | 165 | 6 | Facebase_RNAseq_e9.5_Maxillary Arch_1000_K2 | |
| CoexpressionAtlas | Fetal Liver, SC.STSL.FL, IgM- CD24- CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Fetal Liver, avg-2 | BRIP1 GAS2L3 STXBP4 NEDD4 BLM ZNF608 MKI67 NEIL3 QSER1 CKAP2 EMCN | 3.76e-04 | 410 | 165 | 11 | GSM791122_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | COL6A3 LIMA1 KIF26B STXBP4 COL27A1 CD55 SRSF12 ASXL3 PEAK1 VCAM1 CDON FILIP1L | 3.86e-04 | 480 | 165 | 12 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_200 | 3.88e-04 | 171 | 165 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_200 | |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_top-relative-expression-ranked_1000 | MORC1 NOLC1 BRIP1 VPS50 TEX15 ZIC3 PRDM1 BLM ORC1 MSH6 RIF1 TLE4 ETAA1 ZMYM1 CKAP2 KCTD18 | 4.00e-04 | 781 | 165 | 16 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_500_k-means-cluster#5 | 4.02e-04 | 172 | 165 | 7 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_500_K5 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#2_top-relative-expression-ranked_500 | 4.45e-04 | 46 | 165 | 4 | gudmap_developingGonad_e12.5_epididymis_k2_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#4 | 4.57e-04 | 290 | 165 | 9 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K4 | |
| ToppCell | PND10-Mesenchymal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | COL6A3 MYLK PDGFRL COL27A1 NEDD4 ROBO2 PEAK1 PRDM6 VCAM1 FILIP1L | 4.28e-09 | 196 | 169 | 10 | ace167a40adb7022b365be3c2b1cbd4ba963739a |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.20e-09 | 200 | 169 | 10 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | TET2 CENPC YTHDC1 TRIP12 CEP350 ZNF644 KMT2A ACIN1 ANKRD12 SRRM2 | 5.20e-09 | 200 | 169 | 10 | 12f1685ce8f218433068e090c9d839cd5a1910bf |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.89e-08 | 194 | 169 | 9 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.72e-08 | 197 | 169 | 9 | 26475b9e4d6bfc0ae818dea13d139888ed7e92f1 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.72e-08 | 197 | 169 | 9 | 155e63b33302a87393ace699b2f6d73abe9c5763 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.99e-07 | 177 | 169 | 8 | 2b63f0529ef73e0eede9b7ef1f08b0a0426a9c82 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.35e-07 | 184 | 169 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.35e-07 | 184 | 169 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.35e-07 | 184 | 169 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 5.57e-07 | 185 | 169 | 8 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 5.80e-07 | 186 | 169 | 8 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.04e-07 | 187 | 169 | 8 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.09e-07 | 191 | 169 | 8 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.09e-07 | 191 | 169 | 8 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.09e-07 | 191 | 169 | 8 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.09e-07 | 191 | 169 | 8 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | PND01-03-samps-Mesenchymal|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 7.98e-07 | 194 | 169 | 8 | 4f9bd0ded0dde1df885850714f29e73e992539a5 | |
| ToppCell | Fibroblast-B_(Myofibroblast)|World / shred on cell class and cell subclass (v4) | 8.29e-07 | 195 | 169 | 8 | a8d6416518f226e1ec2d6bdc9d4b90cef5cb1365 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.29e-07 | 195 | 169 | 8 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | PND03-Mesenchymal|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.95e-07 | 197 | 169 | 8 | e3053ef8f604b6892c21c03e12612b49d3d30f23 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.95e-07 | 197 | 169 | 8 | 090a251194da3e2806989d9a522588f83f52da7f | |
| ToppCell | P07-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.95e-07 | 197 | 169 | 8 | b1135378d768fbbe62a75747d1e8653d35252187 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.95e-07 | 197 | 169 | 8 | 43b5f8e917506c1717f9311584901b506ffd2c79 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.30e-07 | 198 | 169 | 8 | a4005a49cf6709b543994ceb51ecd5dc46197fa9 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.30e-07 | 198 | 169 | 8 | a699b365d3b6149f13f02b2e2ae9b6fdce761848 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells-Neuroepithelial_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.00e-06 | 200 | 169 | 8 | 8f8b8c225cdc79baf16fe04be89bdb65e404a055 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.00e-06 | 200 | 169 | 8 | a1f48eca9efb4f3ec3c9ace20f8c9257dd72c4ed | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.85e-06 | 169 | 169 | 7 | b253a4a50c06d36228fcd5d856c57202cbac158f | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-06 | 176 | 169 | 7 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.42e-06 | 178 | 169 | 7 | c77a1d1a9aef0ab51b4408b9e84f201219788ca2 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 6.50e-06 | 183 | 169 | 7 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-06 | 184 | 169 | 7 | 16aa8e88bdd51b1d132d5cf33c29963b384a8bae | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.97e-06 | 185 | 169 | 7 | b4af9ae4c358b48357cb135b740266e1652d886a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.97e-06 | 185 | 169 | 7 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 7.48e-06 | 187 | 169 | 7 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.48e-06 | 187 | 169 | 7 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.48e-06 | 187 | 169 | 7 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.75e-06 | 188 | 169 | 7 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.75e-06 | 188 | 169 | 7 | 95d0a796d62ce6d121e2028c378faffc14b35275 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.75e-06 | 188 | 169 | 7 | 789d1be574e693d7bdd488f3c72c6df788e47b47 | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 8.02e-06 | 189 | 169 | 7 | dc5164591dea45b420798b94dda211be03daa70c | |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | 8.02e-06 | 189 | 169 | 7 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.30e-06 | 190 | 169 | 7 | 474cbbab8f3b0a6881fa6c92edb78e43999f9ab0 | |
| ToppCell | (1)_T_cells-(1)_T_CD4_fh|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 8.30e-06 | 190 | 169 | 7 | 120ca702600373c208a3d032fede0a040736e5cf | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.59e-06 | 191 | 169 | 7 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.89e-06 | 192 | 169 | 7 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.89e-06 | 192 | 169 | 7 | 67d6230e32d446dcb12047fae2c3f1faa80dd720 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.19e-06 | 193 | 169 | 7 | d1445b8bf2bab36e1a326ddb2a528151db016c7d | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 9.19e-06 | 193 | 169 | 7 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.19e-06 | 193 | 169 | 7 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 9.51e-06 | 194 | 169 | 7 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.51e-06 | 194 | 169 | 7 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.51e-06 | 194 | 169 | 7 | 69362e13158033de44f90f3773db6c0f27de8cb3 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.51e-06 | 194 | 169 | 7 | 439d3f17c1f4736122b330e98add9292c7036a8e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.51e-06 | 194 | 169 | 7 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.83e-06 | 195 | 169 | 7 | 2514c1f23424b5fc664d326d31ffd22bafe74ef8 | |
| ToppCell | facs-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.83e-06 | 195 | 169 | 7 | 18b01ab63ee1deae3cf29669d66fff9ca4efc5c4 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.83e-06 | 195 | 169 | 7 | c1435e61e4f0cf457f26ae436936048932ceb0db | |
| ToppCell | P07-Mesenchymal|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.83e-06 | 195 | 169 | 7 | 859764b605866b6c3e6edd0698670ca9c0f20745 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.83e-06 | 195 | 169 | 7 | c96755d2eb98112b703b5dbee9c88730ace7dcbf | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 9.83e-06 | 195 | 169 | 7 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | E17.5-Mesenchymal-myocytic_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.83e-06 | 195 | 169 | 7 | 01a750d660993017af00736215cbcff2de5909c1 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.02e-05 | 196 | 169 | 7 | e4d04e1f82779e8afd4e32bbe38d1d3f6f64ab50 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.02e-05 | 196 | 169 | 7 | f0fd7db22985d2bc84dc8bcbdb2d552e280121dd | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.02e-05 | 196 | 169 | 7 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 1.02e-05 | 196 | 169 | 7 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.02e-05 | 196 | 169 | 7 | ca91d5e325875e7444809b80fcbd491d8899ea36 | |
| ToppCell | P07-Mesenchymal-myocytic_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.05e-05 | 197 | 169 | 7 | 378299fe2ec6ed2fc858febb78ff1ac0898e457d | |
| ToppCell | MatrixFB|World / shred on cell class and cell subclass (v4) | 1.05e-05 | 197 | 169 | 7 | e325de44e32021a36fffb7b7e88167b46bb051c7 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.05e-05 | 197 | 169 | 7 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.05e-05 | 197 | 169 | 7 | d669d90c3f9e98b41bcbc49dbdc5698e0b42597c | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.05e-05 | 197 | 169 | 7 | 9d7a1c7dc70ba5e35645f19f9e056e4fa2494aa0 | |
| ToppCell | PND14-Mesenchymal|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.05e-05 | 197 | 169 | 7 | 9a14bc2e7d6081e2ab0e2e5555fc8804f13d3dbe | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.05e-05 | 197 | 169 | 7 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.05e-05 | 197 | 169 | 7 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.09e-05 | 198 | 169 | 7 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.09e-05 | 198 | 169 | 7 | 0993d6895c0e4f360998ce35abea4ec3dd13e048 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.09e-05 | 198 | 169 | 7 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.09e-05 | 198 | 169 | 7 | f088badb90c6c2d916195f5649eda102119c9ac6 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.09e-05 | 198 | 169 | 7 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 1.12e-05 | 199 | 169 | 7 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.12e-05 | 199 | 169 | 7 | 40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a | |
| ToppCell | 18-Airway-Mesenchymal-Mesenchyme_RSPO2+|Airway / Age, Tissue, Lineage and Cell class | 1.12e-05 | 199 | 169 | 7 | 7ac35e8f45dcdc702422dabd8f3e4d03e2bf61af | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.12e-05 | 199 | 169 | 7 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.12e-05 | 199 | 169 | 7 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.16e-05 | 200 | 169 | 7 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 1.16e-05 | 200 | 169 | 7 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-05 | 200 | 169 | 7 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.16e-05 | 200 | 169 | 7 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-05 | 200 | 169 | 7 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-05 | 200 | 169 | 7 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.16e-05 | 200 | 169 | 7 | b441b3771fb7d9ee7b7a104afc35e466aace2da2 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.16e-05 | 200 | 169 | 7 | be55cef682ba87250dad97689332c8820b3a7420 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-05 | 200 | 169 | 7 | af3dc76b4507bf4edd265169f5dfbbb8a19eb394 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D122|Adult / Lineage, Cell type, age group and donor | 2.18e-05 | 148 | 169 | 6 | 81a1e6fdd942a612bf523c59b8b4974f6ca1fdce | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.26e-05 | 149 | 169 | 6 | 3980fa4f1986a2f164a1826ea043fb71f1d756cd | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.29e-05 | 167 | 169 | 6 | 50c29ea660bf07b890e4ac1a1985d0761d863dee | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.29e-05 | 167 | 169 | 6 | bc132b51dec4e8f1cd2b2cd89f83641976e09292 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Dendritic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.44e-05 | 168 | 169 | 6 | 9b8a74abb83c64f0b5829dcb4275f722c82b45dc | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 7.66e-07 | 179 | 165 | 10 | 5822_DN | |
| Drug | deoxynivalenol | NOLC1 RBM15 TCOF1 MAP4 CD55 MUC16 NR1D1 CREBBP MKI67 KMT2A ACIN1 ATF1 DNAJC1 SRRM2 IL2 | 2.40e-06 | 481 | 165 | 15 | ctd:C007262 |
| Drug | Vincristine | RBM15 LIMA1 BRIP1 CENPC RBL1 ZMYND8 CD55 GON4L GAS7 CREBBP BLM PCF11 DIP2A RIF1 SENP1 XIRP2 PTPRO MKI67 LAMP3 AKAP10 LRBA IL2 LCOR VCAM1 | 4.76e-06 | 1182 | 165 | 24 | ctd:D014750 |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | ZMYND8 NR3C1 CREBBP CEP350 GRAMD1B BAZ1A NEIL3 ANKRD12 EIF2AK3 | 6.86e-06 | 180 | 165 | 9 | 4541_DN |
| Drug | Thioguanosine [85-31-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 9.34e-06 | 187 | 165 | 9 | 4989_DN | |
| Drug | Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 9.75e-06 | 188 | 165 | 9 | 4845_DN | |
| Drug | Droperidol [548-73-2]; Down 200; 10.6uM; PC3; HT_HG-U133A | 1.36e-05 | 196 | 165 | 9 | 4629_DN | |
| Drug | Ethosuximide [77-67-8]; Down 200; 28.4uM; HL60; HG-U133A | 1.36e-05 | 196 | 165 | 9 | 1433_DN | |
| Drug | trifluoperazine dihydrochloride; Down 200; 10uM; PC3; HT_HG-U133A | 1.42e-05 | 197 | 165 | 9 | 1224_DN | |
| Drug | Scopolamine hydrochloride [55-16-3]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.42e-05 | 197 | 165 | 9 | 3357_UP | |
| Drug | tamoxifen citrate; Up 200; 1uM; ssMCF7; HG-U133A | 1.60e-05 | 200 | 165 | 9 | 375_UP | |
| Drug | nordihydroguaiaretic acid; Up 200; 1uM; HL60; HT_HG-U133A | MAP4 KIAA0319L GON4L SH3D21 MTUS1 AKAP10 ANKRD12 MARK2 ADGRE1 | 1.60e-05 | 200 | 165 | 9 | 1164_UP |
| Drug | Magnetite Nanoparticles | TET2 MYLK ZNF280D RBL1 STXBP4 RTN4 VPS50 ZMYND8 NR3C1 CREBBP PRDM1 BLM GRAMD1B RIF1 BAZ1A ZNF644 MKI67 ANKRD12 QSER1 ADGRE1 EFCAB7 IL2 ZMYM3 SOAT1 | 2.60e-05 | 1310 | 165 | 24 | ctd:D058185 |
| Drug | ZNS 114-666 | 2.77e-05 | 49 | 165 | 5 | CID000409441 | |
| Drug | 2,4,4'-trichlorobiphenyl | COL6A3 BRIP1 KIF26B RBL1 ANKS1B GAS7 NR3C1 DCX ESCO1 USP31 MSH6 SENP1 SHANK2 BAZ1A ASXL3 MKI67 ROBO2 NEIL3 AKAP10 ANKRD12 QSER1 CKAP2 LRBA NOVA1 CDON | 3.02e-05 | 1411 | 165 | 25 | ctd:C081766 |
| Drug | Clorgyline | 3.20e-05 | 168 | 165 | 8 | ctd:D003010 | |
| Drug | Lanatoside C [17575-22-3]; Up 200; 4uM; HL60; HT_HG-U133A | 3.33e-05 | 169 | 165 | 8 | 2193_UP | |
| Drug | torcetrapib | NCOA3 LIMA1 AFF2 MAP4 CD55 NR3C1 RIF1 LPCAT2 USP42 TLE4 KMT2A | 4.21e-05 | 342 | 165 | 11 | ctd:C483909 |
| Drug | 2,4,5,2',5'-pentachlorobiphenyl | COL6A3 BRIP1 KIF26B RBL1 ANKS1B GAS7 NR3C1 DCX ESCO1 USP31 MSH6 SENP1 SHANK2 BAZ1A ASXL3 MKI67 ROBO2 NEIL3 AKAP10 ANKRD12 QSER1 CKAP2 LRBA NOVA1 CDON | 4.27e-05 | 1441 | 165 | 25 | ctd:C009828 |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 5.02e-05 | 179 | 165 | 8 | 2105_DN | |
| Drug | WR-77913 | 5.22e-05 | 2 | 165 | 2 | CID000113816 | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 5.86e-05 | 183 | 165 | 8 | 7498_DN | |
| Drug | Pyrvinium pamoate [3546-41-6]; Down 200; 3.4uM; MCF7; HT_HG-U133A | 6.33e-05 | 185 | 165 | 8 | 5439_DN | |
| Drug | chrysene | NCOA3 MYLK ZNF280D TCOF1 KIF26B ZMYND8 CD55 MUC16 YTHDC1 NR1D1 MKI67 ACIN1 ANKRD12 EML1 CKAP2 SRRM2 VCAM1 EMCN | 6.46e-05 | 871 | 165 | 18 | ctd:C031180 |
| Drug | Apigenin [520-36-5]; Down 200; 14.8uM; PC3; HT_HG-U133A | 6.57e-05 | 186 | 165 | 8 | 4578_DN | |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 7.08e-05 | 188 | 165 | 8 | 6735_DN | |
| Drug | Thioguanosine [85-31-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 7.63e-05 | 190 | 165 | 8 | 2619_DN | |
| Drug | cox-2 inhibitor I; Up 200; 10uM; MCF7; HG-U133A | 7.63e-05 | 190 | 165 | 8 | 612_UP | |
| Drug | Trifluridine [70-00-8]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 8.51e-05 | 193 | 165 | 8 | 7176_UP | |
| Drug | 0316684-0000 [391209-55-5]; Up 200; 10uM; PC3; HT_HG-U133A | 8.51e-05 | 193 | 165 | 8 | 7057_UP | |
| Drug | (-) -Levobunolol hydrochloride [27912-14-7]; Up 200; 12.2uM; HL60; HT_HG-U133A | 8.51e-05 | 193 | 165 | 8 | 3015_UP | |
| Drug | Verapamyl hydrochloride [152-11-4]; Down 200; 8.2uM; HL60; HG-U133A | 8.82e-05 | 194 | 165 | 8 | 2009_DN | |
| Drug | Skimmianine [83-95-4]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 8.82e-05 | 194 | 165 | 8 | 6242_UP | |
| Drug | Cephalothin sodium salt [58-71-9]; Up 200; 9.6uM; HL60; HT_HG-U133A | 9.14e-05 | 195 | 165 | 8 | 2517_UP | |
| Drug | Cefadroxil [50370-12-2]; Up 200; 11uM; HL60; HT_HG-U133A | 9.47e-05 | 196 | 165 | 8 | 1323_UP | |
| Drug | GSK-3beta Inhibitor VIII; Up 200; 10uM; MCF7; HT_HG-U133A | 9.47e-05 | 196 | 165 | 8 | 7092_UP | |
| Drug | Tocopherol (R,S) [10191-41-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 9.47e-05 | 196 | 165 | 8 | 3256_UP | |
| Drug | phenformin hydrochloride; Up 200; 10uM; MCF7; HG-U133A | 9.81e-05 | 197 | 165 | 8 | 21_UP | |
| Drug | Hydrastine hydrochloride [5936-28-7]; Down 200; 9.6uM; HL60; HG-U133A | 9.81e-05 | 197 | 165 | 8 | 1740_DN | |
| Drug | Picotamide monohydrate [80530-63-8]; Down 200; 10.2uM; PC3; HT_HG-U133A | 9.81e-05 | 197 | 165 | 8 | 2070_DN | |
| Drug | Seneciphylline [480-81-9]; Up 200; 12uM; HL60; HT_HG-U133A | 9.81e-05 | 197 | 165 | 8 | 2140_UP | |
| Drug | thioridazine hydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A | 1.02e-04 | 198 | 165 | 8 | 6989_DN | |
| Drug | Miconazole [22916-47-8]; Down 200; 9.6uM; HL60; HG-U133A | 1.02e-04 | 198 | 165 | 8 | 1977_DN | |
| Drug | Syrosingopine [84-36-6]; Down 200; 6uM; HL60; HG-U133A | 1.02e-04 | 198 | 165 | 8 | 1761_DN | |
| Drug | HA-1077 dihydrochloride; Down 200; 10uM; PC3; HG-U133A | 1.02e-04 | 198 | 165 | 8 | 436_DN | |
| Drug | Dorzolamide hydrochloride [130693-82-2]; Down 200; 11uM; MCF7; HT_HG-U133A | 1.02e-04 | 198 | 165 | 8 | 3565_DN | |
| Drug | butein; Down 200; 10uM; MCF7; HG-U133A | 1.02e-04 | 198 | 165 | 8 | 607_DN | |
| Drug | Levocabastine hydrochloride [79547-78-7]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 1.05e-04 | 199 | 165 | 8 | 7009_DN | |
| Drug | Cefoxitin sodium salt [33564-30-6]; Down 200; 8.8uM; PC3; HT_HG-U133A | 1.05e-04 | 199 | 165 | 8 | 7148_DN | |
| Drug | Trolox [53188-07-1]; Up 200; 16uM; HL60; HG-U133A | 1.05e-04 | 199 | 165 | 8 | 1734_UP | |
| Drug | Succimer | TET2 MYLK ZNF280D RBL1 STXBP4 RTN4 VPS50 ZMYND8 NR3C1 CREBBP PRDM1 BLM GRAMD1B RIF1 BAZ1A ZNF644 MKI67 ANKRD12 QSER1 EFCAB7 ZMYM3 SOAT1 | 1.23e-04 | 1264 | 165 | 22 | ctd:D004113 |
| Disease | leukemia | 5.38e-07 | 55 | 160 | 6 | C0023418 | |
| Disease | Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13) | 2.92e-05 | 2 | 160 | 2 | C4706584 | |
| Disease | subcortical band heterotopia (is_implicated_in) | 2.92e-05 | 2 | 160 | 2 | DOID:0111169 (is_implicated_in) | |
| Disease | Leukemia, Myelocytic, Acute | 4.63e-05 | 173 | 160 | 7 | C0023467 | |
| Disease | aortic measurement | 7.20e-05 | 251 | 160 | 8 | EFO_0020865 | |
| Disease | Neurodevelopmental Disorders | 1.56e-04 | 93 | 160 | 5 | C1535926 | |
| Disease | Subcortical Band Heterotopia | 1.74e-04 | 4 | 160 | 2 | C1848201 | |
| Disease | interstitial cystitis (is_marker_for) | 2.89e-04 | 5 | 160 | 2 | DOID:13949 (is_marker_for) | |
| Disease | creatine kinase measurement | 3.00e-04 | 59 | 160 | 4 | EFO_0004534 | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 3.42e-04 | 61 | 160 | 4 | C1961102 | |
| Disease | Acute monocytic leukemia | 3.71e-04 | 26 | 160 | 3 | C0023465 | |
| Disease | prostate carcinoma, breast carcinoma, ovarian carcinoma | 4.16e-04 | 27 | 160 | 3 | EFO_0000305, EFO_0001075, EFO_0001663 | |
| Disease | 2-myristoyl-GPC (14:0) measurement | 4.32e-04 | 6 | 160 | 2 | EFO_0800242 | |
| Disease | 1-myristoyl-GPC (14:0) measurement | 4.32e-04 | 6 | 160 | 2 | EFO_0800221 | |
| Disease | Treacher Collins syndrome (implicated_via_orthology) | 4.32e-04 | 6 | 160 | 2 | DOID:2908 (implicated_via_orthology) | |
| Disease | breast carcinoma (is_marker_for) | 4.62e-04 | 66 | 160 | 4 | DOID:3459 (is_marker_for) | |
| Disease | Miller Dieker syndrome | 5.15e-04 | 29 | 160 | 3 | C0265219 | |
| Disease | cup-to-disc ratio measurement | 5.93e-04 | 430 | 160 | 9 | EFO_0006939 | |
| Disease | insomnia measurement | 7.33e-04 | 443 | 160 | 9 | EFO_0007876 | |
| Disease | Unilateral agenesis of kidney | 8.01e-04 | 8 | 160 | 2 | C0266294 | |
| Disease | Fanconi anemia (implicated_via_orthology) | 8.01e-04 | 8 | 160 | 2 | DOID:13636 (implicated_via_orthology) | |
| Disease | diffuse large B-cell lymphoma (is_marker_for) | 8.01e-04 | 8 | 160 | 2 | DOID:0050745 (is_marker_for) | |
| Disease | optic disc size measurement | 9.13e-04 | 205 | 160 | 6 | EFO_0004832 | |
| Disease | hypothyroidism (biomarker_via_orthology) | 9.56e-04 | 80 | 160 | 4 | DOID:1459 (biomarker_via_orthology) | |
| Disease | lymphocyte count | TET2 LIMA1 SPAST RBL1 RTN4 C19orf47 TRIP12 GRAMD1B DIP2A TLE4 ZNF644 ROBO2 PPIP5K2 ADGRE1 IL2 VCAM1 MRTFA PLCE1 | 1.02e-03 | 1464 | 160 | 18 | EFO_0004587 |
| Disease | acute myeloid leukemia (is_implicated_in) | 1.15e-03 | 84 | 160 | 4 | DOID:9119 (is_implicated_in) | |
| Disease | vital capacity | TET2 ATXN2L NCOA3 COL6A3 PCLO ARFGEF2 NR3C1 TRIP12 SENP1 MYPN RPRD2 LRBA EIF2AK3 FILIP1L PLCE1 PDZD2 | 1.16e-03 | 1236 | 160 | 16 | EFO_0004312 |
| Disease | Congenital small ears | 1.43e-03 | 41 | 160 | 3 | C0152423 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.47e-03 | 152 | 160 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | delta-5 desaturase measurement | 1.56e-03 | 11 | 160 | 2 | EFO_0007764 | |
| Disease | chronic kidney disease, Proteinuria | 1.56e-03 | 11 | 160 | 2 | EFO_0003884, HP_0000093 | |
| Disease | brain connectivity measurement | 1.59e-03 | 400 | 160 | 8 | EFO_0005210 | |
| Disease | unipolar depression, bipolar disorder | 1.65e-03 | 156 | 160 | 5 | EFO_0003761, MONDO_0004985 | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 1.86e-03 | 12 | 160 | 2 | DOID:9119 (implicated_via_orthology) | |
| Disease | Prostatic Neoplasms | 2.03e-03 | 616 | 160 | 10 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 2.03e-03 | 616 | 160 | 10 | C0376358 | |
| Disease | retinal vasculature measurement | 2.12e-03 | 517 | 160 | 9 | EFO_0010554 | |
| Disease | esophageal squamous cell carcinoma | 2.19e-03 | 13 | 160 | 2 | EFO_0005922 | |
| Disease | methylcobalamin deficiency type cblE, response to antineoplastic agent | 2.19e-03 | 13 | 160 | 2 | GO_0097327, MONDO_0009354 | |
| Disease | Malignant neoplasm of breast | NCOA3 BRIP1 SPAST STXBP4 ARFGEF2 NUP214 NEDD4 MSH6 RIF1 OTOF ZNF644 MKI67 LRBA MTDH | 2.21e-03 | 1074 | 160 | 14 | C0006142 |
| Disease | handedness | 2.69e-03 | 106 | 160 | 4 | EFO_0009902 | |
| Disease | Myocardial Ischemia | 2.78e-03 | 176 | 160 | 5 | C0151744 | |
| Disease | sexual dimorphism measurement | TET2 ATXN2L EXOSC9 LIMA1 RBL1 RTN4 NR3C1 PIERCE2 ZNF608 ATF1 ASXL2 DNAJC1 LCOR PRDM6 | 2.88e-03 | 1106 | 160 | 14 | EFO_0021796 |
| Disease | diffuse plaque measurement | COL6A3 KIF26B ANKS1B PHF2 MSH6 SHANK2 USP42 NAV3 ROBO2 ADGRE1 EMCN | 2.93e-03 | 758 | 160 | 11 | EFO_0010699 |
| Disease | myelodysplastic syndrome (implicated_via_orthology) | 2.93e-03 | 15 | 160 | 2 | DOID:0050908 (implicated_via_orthology) | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 3.14e-03 | 181 | 160 | 5 | DOID:684 (is_implicated_in) | |
| Disease | teratocarcinoma-derived growth factor 1 measurement | 3.34e-03 | 16 | 160 | 2 | EFO_0008297 | |
| Disease | Pontoneocerebellar hypoplasia | 3.34e-03 | 16 | 160 | 2 | cv:C1261175 | |
| Disease | factor VII activating protease measurement | 3.34e-03 | 55 | 160 | 3 | EFO_0009368 | |
| Disease | R-6-hydroxywarfarin measurement | 3.50e-03 | 114 | 160 | 4 | EFO_0803327 | |
| Disease | Carcinoma, Granular Cell | 3.72e-03 | 116 | 160 | 4 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 3.72e-03 | 116 | 160 | 4 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 3.72e-03 | 116 | 160 | 4 | C0205642 | |
| Disease | Carcinoma, Cribriform | 3.72e-03 | 116 | 160 | 4 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 3.72e-03 | 116 | 160 | 4 | C0205641 | |
| Disease | Adenocarcinoma | 3.72e-03 | 116 | 160 | 4 | C0001418 | |
| Disease | Dystonia, Limb | 3.77e-03 | 17 | 160 | 2 | C0751093 | |
| Disease | Dystonia, Diurnal | 3.77e-03 | 17 | 160 | 2 | C0393610 | |
| Disease | lupus nephritis (is_marker_for) | 3.77e-03 | 17 | 160 | 2 | DOID:0080162 (is_marker_for) | |
| Disease | graft-versus-host disease (is_implicated_in) | 3.77e-03 | 17 | 160 | 2 | DOID:0081267 (is_implicated_in) | |
| Disease | cytokine measurement | 3.79e-03 | 461 | 160 | 8 | EFO_0004873 | |
| Disease | sinusitis (is_marker_for) | 4.22e-03 | 18 | 160 | 2 | DOID:0050127 (is_marker_for) | |
| Disease | Dystonia, Paroxysmal | 4.22e-03 | 18 | 160 | 2 | C0393588 | |
| Disease | parahippocampal gyrus volume measurement | 4.22e-03 | 18 | 160 | 2 | EFO_0010318 | |
| Disease | free androgen index | 4.43e-03 | 374 | 160 | 7 | EFO_0007005 | |
| Disease | diet measurement | KIF26B RTN4 ARFGEF2 UBAP1 TEX15 PHF2 MSH6 ZNF608 MUC17 ROBO2 AKAP10 DNAJC1 EMCN | 4.82e-03 | 1049 | 160 | 13 | EFO_0008111 |
| Disease | cholangiocarcinoma (is_marker_for) | 5.12e-03 | 64 | 160 | 3 | DOID:4947 (is_marker_for) | |
| Disease | susceptibility to vaginal yeast infection measurement | 5.34e-03 | 65 | 160 | 3 | EFO_0008412 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NPAKSNTSKPNTVKS | 556 | Q6N043 | |
| NTSKPNTVKSNASKP | 561 | Q6N043 | |
| NTVKSNASKPNTSKP | 566 | Q6N043 | |
| ATTQKKPSISITTES | 856 | Q9UKV3 | |
| TPISSKSQSKTTQSA | 1351 | O94986 | |
| KSQSKTTQSALPLTS | 1356 | O94986 | |
| KASKTTTSVPVLPNS | 496 | Q13939 | |
| DLTKNTTEKLQPSSP | 866 | Q9NZJ5 | |
| SPQPALTVKAKATSS | 306 | Q8N9M1 | |
| TVKQSSLAEPVSPSK | 176 | O43572 | |
| PKKASSATITVTNTA | 976 | P51816 | |
| SQAQSKPTTPEKTDL | 236 | Q9Y6D5 | |
| ASQSTSPSQPRKKIF | 1071 | Q92793 | |
| TPAQKKTPSSSSRQK | 161 | Q6UB98 | |
| KSTVQNSRPIKTATT | 391 | Q96KC8 | |
| QLPKKSITNSTLTST | 276 | Q3KR37 | |
| ESQESLVTSPSKPKS | 516 | Q76L83 | |
| KSQPVSKPESRASTS | 1026 | Q9C0F0 | |
| FNPTKPLLSVNKSTS | 666 | Q8WWM7 | |
| SRSQQSTPKTTVSSK | 1296 | Q9NRL2 | |
| TKPQPVNTSSVTVKS | 216 | Q8WWK9 | |
| TSTASSKLKSPSQKQ | 756 | Q96T37 | |
| AGTTKNSSNKPAVTT | 381 | Q14978 | |
| NSSNKPAVTTKSPAV | 386 | Q14978 | |
| KSCSTEQPLTSTKTP | 281 | Q2KHR3 | |
| TVQAKPSSSSKTSDP | 1456 | Q2KHR3 | |
| SETVPASQPLSKKTS | 766 | A6NNM3 | |
| SETVPASQPLSKKTS | 766 | A6NJZ7 | |
| FTQTKITSPSQRPKT | 306 | Q8N109 | |
| TKSTPSNLTKTQGSQ | 336 | Q9UPP5 | |
| KVASSPASSQSTPVK | 801 | Q86VD1 | |
| PASSQSTPVKETVRK | 806 | Q86VD1 | |
| PVESPSQKTKSETVT | 311 | Q7Z6G8 | |
| TSKKAEQTSTQLPTT | 3806 | Q8WXI7 | |
| TKPSITTPNTESLQK | 36 | Q9ULC0 | |
| TLPNAVSTLQSSKPK | 111 | Q9ULC0 | |
| VSTLQSSKPKTETQS | 116 | Q9ULC0 | |
| TAPQTPVLQKTSSSI | 331 | Q15746 | |
| TKPLATTQPAKTSTS | 701 | P27816 | |
| TTQPAKTSTSKAKTQ | 706 | P27816 | |
| KTSTSKAKTQPTSLP | 711 | P27816 | |
| SFQSTSVKSPKTVSP | 596 | Q9UHB6 | |
| RSSVPSSENVNKKSS | 71 | P46934 | |
| HPSKKTTNDITQPSS | 431 | Q8TAT5 | |
| TTNDITQPSSKVNIS | 436 | Q8TAT5 | |
| SKTTTTSGRNISKPD | 701 | Q9ULD2 | |
| TPSTQQVKSSEKTQI | 261 | Q8IZA0 | |
| TSKKTAESVTSLPSQ | 466 | O95208 | |
| ATQSPVHPNKSVKSS | 1521 | Q2KJY2 | |
| SLVSQGKPQSTTKSR | 3036 | Q5SZK8 | |
| ILSEKSVPQASSPKS | 941 | Q8NCM2 | |
| PTSQKTTTKTTTPNA | 311 | P08174 | |
| STTTVKSKDTQEPNL | 5541 | Q5CZC0 | |
| FTQTKITSPSQRPKT | 306 | Q8NHK3 | |
| IRTQTTSAKQEKAPS | 411 | Q06265 | |
| VTTTSAVSKSSPQPQ | 666 | Q9Y6V0 | |
| SATTKPDIPSSKVQS | 771 | Q9Y6V0 | |
| TESSSQKTAVPPQVK | 1141 | Q9Y6V0 | |
| QSSQQSPKPSVIKSR | 4841 | Q9Y6V0 | |
| NSTKNQSLPKASPVT | 26 | Q96JN0 | |
| TSPTAATTQNPVLSK | 41 | Q96JN0 | |
| SPLVSTAKTAKTPTT | 746 | Q02505 | |
| TAKTAKTPTTNLVTT | 751 | Q02505 | |
| KKSTRSLSTTQVESP | 561 | O15018 | |
| TNISSKTIPVKSPNL | 576 | Q9H792 | |
| APQTTDSPTTKVQKD | 831 | Q9H792 | |
| TTKGSPSQSLSKPIT | 556 | Q8IVL0 | |
| SSVTPTLSQLTDQKS | 166 | Q6ZU69 | |
| SKTETITTEKQSQPT | 21 | P34910 | |
| DPKTLQTATSLSKPQ | 41 | H3BRN8 | |
| KKSAVSPSTFNTSIP | 1731 | P50851 | |
| TTKINKVSPSTDFIS | 211 | A6NHS7 | |
| KASSTSLTSTQPTKT | 1351 | P35658 | |
| VKIPTTTPATTKNTA | 81 | Q9UQV4 | |
| SSPSNVTLPQVKTEK | 266 | P04150 | |
| TAPASSSKSQTEVPK | 601 | P46013 | |
| VDTPTSSKPQSKRSL | 1501 | P46013 | |
| SPQPESFKTSRSSKQ | 2466 | P46013 | |
| STRDPVKSQSKSNTS | 2976 | P46013 | |
| RKETPSATKQATSIS | 316 | P52701 | |
| NTTIPTKKSQVFSTA | 461 | P38646 | |
| KSQKQSLTPSFQSPA | 1146 | Q9C091 | |
| SVKSRITINPDTSKN | 86 | A0A0B4J1U7 | |
| PSSSSINNSSSKPTK | 841 | O15265 | |
| SKTVKNTSRANTSPD | 421 | Q9NY74 | |
| SSQKTKLQEPVAVSS | 761 | Q16827 | |
| TTPRKKQNSNSQSTP | 461 | A8CG34 | |
| KSSKLAPTTQQRSVV | 406 | Q9NQX0 | |
| SRSTSPTFNKQTKRV | 986 | Q9BX63 | |
| TLNQSDTKTSKTIPS | 321 | O94913 | |
| KEVQTTPSTASNKVS | 516 | Q7L5N7 | |
| TLKSTPKTTSVSQNT | 111 | Q8N131 | |
| ITSPSKRSQPDKLQT | 271 | Q13415 | |
| PSTSTQIKVKNSASV | 281 | Q6PI47 | |
| SRVSPSKSTSNITKL | 111 | P20393 | |
| ITKQPPVTQSKTASD | 161 | Q8TES7 | |
| PVTQSKTASDKSPST | 166 | Q8TES7 | |
| LVTNSAPTSSSTKKT | 16 | P60568 | |
| APTSSSTKKTQLQLE | 21 | P60568 | |
| TTQNTPTVKKSRDTA | 121 | P54132 | |
| QPKSSQTKSCQSQPS | 966 | Q9BX69 | |
| QTKSCQSQPSQTKPS | 971 | Q9BX69 | |
| SSLPKDVSPTQAKSS | 541 | Q8WTW3 | |
| FSSQKSTPSESPRTK | 11 | A8K855 | |
| FSTNSTKSVPNSTRK | 51 | Q03188 | |
| NKTTNKVTSSITITP | 1101 | Q4L180 | |
| ITKKPQAPSNNASSS | 391 | Q86XJ1 | |
| VSLPQSSTKTQTAPK | 616 | Q86XJ1 | |
| SSTKTQTAPKSAQTV | 621 | Q86XJ1 | |
| EKTASSKNTQASSPP | 676 | Q4KMG0 | |
| KPVTTTTKPVTTTTK | 2881 | P12111 | |
| SSQLSTPKSKQSPIS | 321 | O43602 | |
| TGVETTTPSKQSNNK | 51 | P0CF74 | |
| SQSAKPVSQPRKSTQ | 186 | Q3T8J9 | |
| PTAKPQIKTLSSASE | 2116 | Q5VT06 | |
| TAPSSFTKSALPTQK | 391 | Q8IZC6 | |
| LERKKTTPTPSTNSV | 461 | Q7KZI7 | |
| SKSNTKQNSVPPSQT | 546 | Q86UE4 | |
| KQNSVPPSQTKSETS | 551 | Q86UE4 | |
| PKTKVTTVTSAQKSS | 541 | Q9P2N6 | |
| TVTPKSSPTDCQKTT | 121 | A0A0U1RQI7 | |
| ATTPASRKSSKQVSQ | 1286 | Q03164 | |
| SLPPTKKEQCSSTQS | 151 | Q5FWF5 | |
| TAVPATKSNIKRTSS | 121 | O00423 | |
| QTTAAAPKQQKSRPT | 71 | Q14689 | |
| PQLSAPITTKTDKTS | 496 | Q9ULU4 | |
| SVPTKPTENISKASS | 401 | Q5VT52 | |
| TAQLKTTPTQPSEQK | 231 | O95104 | |
| KPVQTSKTLASSSSS | 246 | Q9Y467 | |
| SATVNVTTKKTPPSQ | 891 | Q9P232 | |
| VSTLKSNPATPTSKL | 121 | Q32NC0 | |
| VTALTTNVSNKRSKP | 226 | Q9HC10 | |
| RIKQTLPSSPTTTKS | 146 | P51513 | |
| TAVPTNTTIKSNPTS | 4111 | Q685J3 | |
| PQSSKSTVVKSLIDN | 181 | Q9Y2M0 | |
| TEKNTSTKTSNPFLV | 506 | Q9NQC3 | |
| SKPTTKSQKTLPSTS | 236 | C9JL84 | |
| KKVSSTNNTPVPRLT | 786 | A2RUB1 | |
| SAKEKSSTVPIPTVN | 281 | P35610 | |
| ISPKNTVISVNPSTK | 221 | P19320 | |
| TQSPVEKDSPAKTQS | 11 | Q8IUE1 | |
| TSTQRPSSPETATKQ | 316 | Q9UQ35 | |
| SESPSLQSKSQTSPK | 1081 | Q9UQ35 | |
| TQSPVEKDSPAKTQS | 11 | Q8IUE0 | |
| KRKLTPNTTSPSTST | 956 | O75151 | |
| KRSKTQTPQQRSVSS | 206 | A4FU49 | |
| PSVKPAQVKASSVST | 216 | Q13428 | |
| TLPATSPQSTSVQAK | 1106 | Q13428 | |
| DTTNKKTTTPKSSQR | 2196 | Q9P212 | |
| TNQESKVKSPVSLTA | 741 | P28749 | |
| SETVPASQPLSKKTS | 766 | Q9UFD9 | |
| SPSPLNNISSTVTVK | 1236 | Q5UIP0 | |
| PSRTPLIQTKKSTSS | 66 | A0A1B0GUV7 | |
| SSSPSKKQSKENTIT | 161 | O60861 | |
| ITQPSKVSNQDSKSP | 556 | Q9Y6Q9 | |
| SSTIPSSSQEKDPKI | 771 | Q9Y6Q9 | |
| LKVKDSQTPTPSSTF | 321 | Q9P0U3 | |
| QPQISSTKTLSKTAR | 26 | Q99603 | |
| LTQTQSSLKQPSTEK | 221 | O75626 | |
| NRTNKPSTPTTATRK | 296 | Q9UBP0 | |
| INSQPKSRKTSTLQT | 46 | Q8N5I9 | |
| PPSTTILASSNKVKS | 271 | Q15198 | |
| ILIPKTSSTPKTNND | 146 | Q6ZWJ1 | |
| SPSVPKTSASRTQKS | 321 | Q68D10 | |
| KTKASNRTVTQPPLS | 326 | A0A1B0GV85 | |
| TTIPTAKSTPTLIKQ | 196 | Q969V6 | |
| TQHNKVSTSPKITTA | 241 | Q92954 | |
| SIGKSQSSSPQKQTS | 191 | Q8WXF0 | |
| KKSDTPQSPSLNSSQ | 1441 | Q9UPX8 | |
| GKTKPSSQSQTSRIL | 861 | Q14246 | |
| TLTSQTTKTDDPQLK | 201 | P18846 | |
| ATLPPITVTSKTNKD | 586 | A8K7I4 | |
| NTQDKTPSKVTARPS | 871 | Q9ULV3 | |
| SDTQQQPKKSKSRTP | 226 | Q7L0Q8 | |
| KILTDTQSSKPSPTQ | 1976 | A4UGR9 | |
| SVSPSKQPVSTSSKT | 496 | Q96JG6 | |
| KQPVSTSSKTVTLFE | 501 | Q96JG6 | |
| ANSKDTTKTPSAVQT | 436 | O60481 | |
| KPVPSSTITNSAVQS | 551 | Q9H9J4 | |
| TPTRVSSSATKQKVL | 131 | Q9NZ09 | |
| SLNEKSTTPVSKSNT | 311 | Q04727 | |
| PSPASTSSQESKLQK | 26 | Q99469 | |
| EKKPELSSSSQQPSV | 946 | O15014 | |
| SSNEKQTISLPVSTS | 901 | Q8IZM8 | |
| QTISLPVSTSKSRKE | 906 | Q8IZM8 | |
| PEVPQKTTASSTKAQ | 866 | O94885 | |
| SKPQVTDVTKNSVTL | 526 | Q9HCK4 | |
| TSCSPQKTRQSPQTL | 126 | Q8IV63 | |
| SKPLSSSVSNNKRIV | 71 | Q96MU7 | |
| KTLTKQQSTTFPKNS | 641 | Q9H582 | |
| PSKKSISIQRVSQVS | 56 | Q8TF45 | |
| TEKVNTSPSVNTKTT | 1396 | Q9ULD9 | |
| TSPSVNTKTTTESKA | 1401 | Q9ULD9 | |
| SPKKDTTPVISNIVS | 336 | Q5SVZ6 | |
| SVSSPSPQKQKSASA | 1106 | Q70CQ4 | |
| PSSAVVPNTSSRKKN | 1211 | O43314 | |
| LSTKNTTTESVPLKN | 1516 | Q9BXT5 | |
| TTTESVPLKNTVSNP | 1521 | Q9BXT5 | |
| NQAKSPTTTQSPKSS | 1026 | Q14669 | |
| SLSKQQTSTPVLTQP | 226 | Q5T5U3 | |
| LEQQTTSSEKTPTKR | 1081 | Q6N021 | |
| KTPESITSATSKEPQ | 26 | Q5VZQ5 | |
| ESKPQTPSQTKVENS | 776 | Q14202 | |
| QLSPQSKSSSKVTSV | 891 | Q86VM9 | |
| PAVTTSSKQVKAPSS | 701 | Q86TC9 | |
| PKENTLVSKSPSSSS | 636 | P29120 |